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vABSTRACT 
 
 Vesicle budding, membrane trafficking, and lipid metabolism depend on the 
switching of Arf and Rab GTPases from the inactive GDP bound state to the active GTP 
bound state.  However, Arf and Rab GTPases have intrinsic rates of GDP to GTP 
exchange that are much slower (hours to days) than the time scale of the relevant 
trafficking processes (seconds or less).  In cells, the activation of Arf and Rab GTPases is 
tightly regulated by guanine nucleotide exchange factors (GEFs) with Sec7 or Vps9 
domains, respectively. 
 Full length Cytohesins, which have a domain architecture consisting of heptad 
repeats, a Sec7 domain, a pleckstrin homology (PH) domain, and a polybasic motif, have 
100-fold lower exchange activity than the isolated Sec7 domain.  Insights into the low 
exchange activity were obtained by structural, biochemical and kinetic analyses.  It was 
found that the Sec7-PH domain linker and a C-terminal amphipathic helix physically 
block the docking sites for the switch regions of Arf GTPases.  Mutations within either 
element result in partial or complete relief of autoinhibition.  Autohibition is also strongly 
relieved by phosphorylation of protein kinase C (PKC) sites in the polybasic motif of 
Cytohesin-1 or by phosphoinositide head group-dependent binding of active Arf6. 
 Despite unrelated folds, Sec7 and Vps9 domains engage cognate GTPases in a 
strikingly similar manner and supply a critical acidic residue that interacts with an 
invariant lysine residues from phosphate binding (P) loop of the GTPase in the nucleotide 
vi
free complex.  The key acidic residues have also been proposed to disrupt the Mg2+ 
binding site; however, it is not known whether disruption of Mg2+ binding contributes to 
the rate limiting step for nucleotide release.  To investigate the kinetic mechanism for 
catalysis of nucleotide exchange in the absence of autoinhibitory interactions, a detailed 
stopped flow kinetic analysis of the intrinsic and GEF mediated exchange reactions was 
conducted for the isolated catalytic cores.  Using three different fluorescence methods to 
monitor Mg2+ dissociation, formation of the nucleotide free intermediate, and subsequent 
nucleotide binding, the catalytic cores of Cytohesin-1 and Rabex-5 were found to 
robustly accelerate nucleotide exchange on Arf1 and Rab5, respectively, by at least 105-
fold at physiological concentrations of Mg2+.  The acceleration of nucleotide exchange 
was reduced by roughly an order of magnitude at sub-micromolar concentrations of Mg2+.  
In addition, the Cytohesin-1 and Rabex-5 catalytic cores have similarly high catalytic 
efficiencies (kcat/KM) as well as high lower limits on both the rate (kcat) and steady state 
(KM) constants for GDP release at physiological as well as low Mg2+ concentration.  The 
limits on kcat and KM are comparable to the highest values reported for other well 
characterized GEFs and likely reflect dual requirements of membrane targeting and 
autoregulatory mechanisms for tight control of catalytic output.  These results provide a 
solid structural and mechanistic foundation for future experiments to investigate the 
spatial-temporal dynamics of Cytohesin and Rabex-5 activation in cellular contexts. 
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PREFACE 
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of membrane traffic by Rab GTPases. Traffic 10: 1377-1389. 
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Czech, and D. G. Lambright. 2007. Structural basis and mechanism of autoregulation in 3 
phosphoinositide-dependent Grp1 family Arf GTPase exchange factors. Mol Cell 28: 
569-583. 
 
Chapter I contains work previously published in Lee, et al.  Ashwini Mishra and David 
Lambright helped to make some of the figures.   
Chapter II contains work previously published in DiNitto, et al.  Jonathan P. DiNitto 
carried out most of the experimental work.  Meng-tse Lee crystallized and solved the 
autoinhibited structure of Grp163–399 with a single K68A mutation.   
In Chapter III, Meng-tse Lee carried out all of the experimental work discussed in the 
chapter.  Anna Delprato helped to make one construct and carried out some pilot 
experiments.  David Lambright derived the analytical solution for the dual steady state 
model.   
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CHAPTER I 
 
Introduction 
 Eukaryotic cells are compartmentalized into a network of endomembranes.  To 
transport materials between different organelles, cells make use of numerous carrier 
vesicles.  Small Ras-like GTPases of the Arf and Rab families are targeted to different 
cellular locations to direct the timing and specificity of vesicular transport between donor 
and acceptor compartments (Figure 1.1).  Arf GTPases are best known for their ability to 
recruit coat proteins and lipid modifying enzymes to mediate budding of vesicles from 
donor membranes (1).  The vesicles are then transported to the acceptor compartment by 
either diffusion or actin/microtubule based motors.  Once at the acceptor membrane, 
vesicles are tethered to the membrane before fusion, which is mediated by SNARE 
proteins.  Rab GTPases function in the transport and tethering processes by binding to a 
diverse group of effectors, including cargo sorting complexes, motor proteins and 
tethering factors/complexes (2-6)  
 Arf and Rab GTPases are binary switches that cycle between GDP-bound (inactive) 
and GTP-bound (active) conformations.  The intrinsic rates of activation are typically 
much slower (hours to days) than the relevant trafficking processes they are involved 
with.  Because of this, the spatiotemporal cycle of membrane targeting, activation, and 
subsequent inactivation of GTPases is tightly regulated through the interplay of some or 
all of several accessory factors: GDP dissociation inhibitors (GDIs), 
 2 
 
Figure 1.1 Intracellular localization and function of Arf and Rab GTPases.  
ER, Endoplasmic reticulum; IC, ER/Golgi intermediate compartment; MTs, 
microtubules; PI3P, phosphatidylinositol-(3)-phosphate; PIP2, phosphatidylinositol-
bisphosphate ; PIP3, phosphatidylinositol- (3,4,5)-trisphosphate; TGN,  trans-Golgi 
network.  Arrows indicate generic trafficking pathways that may include organelle 
maturation in addition to vesicular/tubular-vesicular transport.  
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GDI displacement factors (GDFs), guanine nucleotide exchange factors (GEFs), effectors 
and GTPase activating proteins (GAPs) (1, 3, 7, 8) (Figure 1.2).  GDIs sequester inactive 
GTPases in the cytoplasm while GDFs mediate the association of inactive GTPases with 
donor membranes by facilitating release from GDI.  GEFs control activation by 
catalyzing the exchange of GDP for GTP, and these activated GTPases bind selectively to 
effectors to mediate several cellular functions as described above.  Finally, GAPs 
promote the inactivation of GTPases by accelerating the hydrolysis of GTP. 
 Most GEFs, effectors and GAPs are multi-domain proteins with signaling roles in 
addition to those mediated by the Arf and Rab GTPase binding domains (1, 6, 9).  
Moreover, one GTPase can recruit a GEF for a second GTPase that will eventually 
replace the first (3).  This process is well documented for Rab5-to-Rab7 conversion 
during endosome maturation (10).  Likewise, downstream GTPases can recruit GAPs for 
upstream GTPases, as has been demonstrated for the yeast Rab GTPase Ypt32, which 
recruits the Ypt1 GAP Gyp1 (11).  
 This thesis attempts to integrate biochemical and structural information to provide a 
detailed understanding of the intra and inter molecular events that drive Arf and Rab 
GTPase activation as mediated by their respective subfamily specific GEFs.  To this end, 
the author investigates the regulation of Cytohesin family Arf GEFs (Chapter II) and 
the kinetic mechanism for the activation of Arf and Rab GTPases by the catalytic cores of 
Cytohesin-1 and Rabex-5 (Chapter III).  Hence in this chapter, the structural mechanisms 
that GTPases exploit to recognize different accessory factors will be described first.  The 
phylogeny and the structural diversity of Arf and Rab GTPases will be considered to  
 4 
 
 
Figure 1.2 Accessory factors in controlling the activation/deactivation cycle of  
  Rab GTPase (Green).   
GDP dissociation inhibitors (GDIs) sequester inactive GTPases in the cytoplasm while 
GDI displacement factors (GDFs) mediate the association of inactive GTPases with 
donor membranes by displacing GDI.  Guanine nucleotide exchange factors (GEFs) 
activate GTPases by catalyzing the exchange of GDP to GTP.  GTP bound GTPases bind 
to effectors to mediate transport and fusion to the acceptor membrane. GTPase activating 
proteins (GAPs) promote the inactivation of GTPases by accelerating the hydrolysis of 
GTP to GDP.  The Rab GTPase cycle is completed by GDI extraction of Rab GTPases 
from the acceptor membrane.  Although GDIs and GDFs have not been reported for Arf 
GTPases, they nevertheless cycle between donor and acceptor membranes in a similar, 
nucleotide-dependent manner.      
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provide insight into the determinants underlying the specificity of accessory factors for 
particular classes/subfamilies of GTPases.  Membrane targeting is intrinsically linked to 
the activation of Arf and Rab GTPases and the different targeting strategies adopted by 
these two GTPase families will be highlighted.  Since this thesis focuses on the activation 
of Arf and Rab GTPases, there will be an in-depth discussion of the kinetic and structural 
mechanisms that GEFs exploit to catalyze nucleotide exchange.  However, GEFs are not 
the sole controllers of the GTPase cycle and some of the regulatory functions of GAPs 
and effectors will also be mentioned.   
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Conserved GTPase domain and molecular switch mechanism 
 
 All GTPases have a conserved 'G domain' domain with a common overall structure 
consisting of a six-stranded central β-sheet surrounded by five α-helices (Figure 1.3).  
Comparisons of the active and inactive structures of GTPases reveal that conformation 
changes are mainly restricted to two regions that are termed switch I and switch II.  A 
Mg2+ cofactor is required for high affinity nucleotide binding and hydrolysis.  
Interactions with guanine nucleotides primarily involve residues from five 'G motifs' that 
are broadly conserved in all GTPases (12, 13).  The G1 motif, commonly referred as the 
'P-loop' (β1/α1 loop), has the consensus sequence GxxxxGKS/T and provides phosphate 
contacts in addition to supplying a Ser/Thr that is coordinated by the Mg2+ ion.  The G2 
motif contains an essential threonine in switch I that contacts both the γ phosphate and 
the Mg2+ ion in the active state.  The G3 motif in the switch II region has the sequence of 
DxxGQ in which the aspartate stabilizes the Mg2+ ion through interaction with a water 
ligand, the glycine contacts the γ phosphate, and the glutamine functions as a catalytic 
residue for the intrinsic GTP hydrolytic reaction.  Finally, the consensus residues in the 
G4 and G5 motifs are responsible for interactions with the guanine base and 
discrimination against other nucleotides.  
 Partial-loss-of-function GTPase variants with altered nucleotide-binding and GTP 
hydrolytic properties are easily generated by mutation of conserved G motif residues.  
The two most widely utilized mutations involve asparagine substitution of the P-loop 
Ser/Thr (SN or TN mutant) and leucine substitution of the glutamine in the DxxGQ motif   
 7 
 
 
Figure 1.3 Structural similarity and diversity within the Rab family. 
(A) Overall structure of a representative Rab GTPase (Rab3) with functional regions 
colored as indicated.  (B) Comparison of inactive GDP-bound Rab GTPase structures 
after superposition with Rab2. Note that the switch regions are either poorly ordered or 
adopt ordered conformations as a result of crystal packing.  (C) Comparison of active 
GppNHp-bound Rab GTPase structures after superposition with Rab3A. Although both 
switch regions adopt stable active conformations, switch 2 exhibits large conformational 
differences between Rab GTPases.  Accession number of all the Rab structures can be 
found in Lee et al., 2009 (14).  
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(QL mutant).  The SN or TN substitution disrupts the Mg2+ binding site, resulting in 
greatly reduced affinity for guanine nucleotides.  In vitro at low Mg2+ concentrations, the 
affinity for GTP is reduced 100-fold without affecting affinity for GDP, suggesting that 
the mutants are 'GDP-locked' (15, 16).  The effects in vivo are more complicated, given 
relatively high cellular concentrations of free Mg2+ and GTP.  In any case, the SN or TN 
mutants are expected to shift the equilibrium towards the GDP/nucleotide free states and 
likely exert dominant negative effects by sequestration of endogenous GEFs, preventing 
GTPase activation and stalling downstream processes. 
 In addition to the canonical conformational changes in the switch regions 
associated with activation, Arf GTPases also undergo a unique toggling of the interswitch 
region.  In the inactive state, a N-terminal amphipathic helix docks onto the interswitch 
region and prevents access by GEFs.  X-ray crystallographic studies comparing the active 
and inactive structures of Arf GTPases revealed a two residue register shift in the 
interswitch region, from a 'down' to an 'up' position upon activation (Figure 1.4), that 
displaces the N-terminal helix from the GTPase core (17, 18).  Binding of the N-terminal 
helix to membranes favors a conformation competent for GEF binding and therefore 
activation.  This will be discussed further in the GEF sections. 
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Figure 1.4 Structural changes of Arf1 when switching from the inactive (GDP) to 
  the active (GTP) state.  
The dashed line indicates the likely location of the N-terminal helix in the Arf1•GTP 
complex.  Images based on Protein Data Bank entries 1HUR (Arf1•GDP), and 1O3Y 
(Arf1•GTP)  
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Phylogeny and structural diversity 
Arf GTPases 
 Encoded by 3 genes in budding yeast and 6 in mammals, the highly conserved Arf 
GTPases can be divided into 3 classes based on sequence homology.  Class I consists of 
Arf1, Arf2 and Arf3, which are >96% identical.  Class II consists of Arf4 and Arf5, 
which share 90% sequence identity with each other and 80% identity with Class I Arf.  
Class III consists of only Arf6, which is the most divergent member (64-69% sequence 
identity with the other Arfs).  In addition, SAR1 and more than 20 Arf like (Arl) GTPases 
can be considered part of the extended Arf family as they share a sequence that codes for 
a N-terminal amphipathic helix in addition to the canonical GTPase domain.  However, 
since the Arf interaction domains in cognate GEFs, GAPs, and effectors have little cross 
specificity for SAR1 and Arl GTPases, further discussion will be restricted to members of 
the immediate Arf family.  
 Members of the same Arf class tend to be functionally redundant.  As predicted 
from the sequence homology, Class I and II Arfs have similar functional properties, 
which differ from that of the Class III Arf6.  Class I and II Arfs localize to the Golgi and 
have overlapping effectors (1). The Class III Arf6 is distinctly localized to the plasma 
membrane as well as endocytic membranes and can utilize a different set of cellular 
effectors, although some are also shared with Class I and II Arfs (1, 19). 
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 Structures solved for the inactive Arf GTPases all feature a retracted interswitch 
region that anchors the N-terminal amphipathic helix (20).  Comparison of GDP bound 
Arf1 and Arf6 shows up to 5Å differences in the switch regions, which is attributed to a 
combination of a shorter linker from the N-terminal helix to the protein core and a slight 
difference (20%) in sequence (18, 21).  Hence, it is thought that the differences in the 
inactive switch conformations of Arf GTPases helps to generate specificity for Arf GEFs.  
 Despite these findings for the inactive state, the structures of active Arf1 and Arf6 
share almost identical switch conformations.  This helps to explain why the isolated Arf 
binding domains of some effectors have in vitro binding affinity for all 3 Arf classes (21, 
22).  In vivo specificity of effectors for different classes of Arfs likely derives from a 
combination of GEF mediated activation, differential cellular location, and subtle 
differences in binding affinity. 
 
Rab GTPases 
 Encoded by 11 genes in budding yeast and ~60 in mammals, the Rab family 
represents the largest and most diverse branch of the small Ras like GTPase superfamily 
(23).  The majority can be hierarchically organized into phylogenetic groups (PGs) that 
contain functionally distinct proteins in addition to subfamilies of highly similar isoforms 
(24).  Subfamily members tend to be functionally similar if not redundant (although 
differences in tissue and possibly sub-cellular distribution might be important) whereas 
group members typically have partially or completely distinguishable functions.    
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Nevertheless, group members are more likely to function in related processes and have 
overlapping subcellular distributions than members of different groups. 
 Crystal structures are available for at least 16 Rab GTPases in the active state and 
17 in the inactive state, with one or more structures for members of seven of the eight 
PGs.  The coverage is sufficient to allow some generalization with respect to 
conformational switching, characteristic family features, and similarity/diversity within 
and between PGs (25).  In the inactive conformation, the switch regions are disordered or 
adopt ordered conformations that depend on crystal packing (Figure 1.3B).  Both 
observations support the view that the switch regions in Rabs are natively unfolded in the 
GDP-bound state.  Conversely, in the active state, the switch regions adopt well defined 
conformations (Figure 1.3C), with the exception of Rab21 where switch II remains 
mobile, at least in the absence of effectors. 
 Tertiary structural differences between Rab GTPases are generally small within 
conserved elements required for nucleotide and Mg2+ binding but strikingly large in 
switch II, interswitch, and the α3/β5 loop (Figure 1.3C).  The active conformation of 
switch I and, in particular, switch II varies substantially between and even within PGs 
(25).  For example, Rab4 and Rab11 from PG2 have dissimilar active conformations as 
do Rab7 and Rab9 from PG7.  In PG5, the active conformation of Rab21 is dissimilar to 
Rab5 and Rab22, which have nearly identical active conformations.  Furthermore, the 
active conformation of Rab4 is more similar to Rab5 and Rab22 than to Rab11.  
Structural diversity in the active switch conformation may be due in part to non-
conservative substitutions within the relatively well conserved switch regions; however, 
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substitutions within the hydrophobic core involving residues proximal to the switch II 
region likely contribute as well.  From an evolutionary perspective, these differences 
presumably reflect selective pressure to achieve functional specificity. 
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Membrane targeting 
Arf GTPases 
 Arf GTPases are unique in having an additional N-terminal amphipathic helix 
(ranging from 13-17 residues) which has the dual role of maintaining the inactive GDP 
bound conformation and assisting membrane association.  In addition, all six Arfs but not 
all Arf like GTPases have an N-terminal glycine at the second position that undergoes 
myristoylation (21, 26-28).  Upon activation by GEFs on the membrane, the interswitch 
toggle discussed above fully exposes the myristoylated N-terminus for bilayer insertion 
(21, 29).  Unlike Rab GTPases, no specific GDP dissociation factor (GDI) has been 
identified to help extract GDP bound Arf GTPases from the membrane.  Consequently, 
Arf GTPases are believed to be weakly associated with the membrane after GTP 
hydrolysis, with the notable exception of Arf6 (pI = 8.6), which is more basic than the 
other Arfs (pI = 6-7) (19, 30).  
 
Rab GTPases 
 The membrane targeting of Rab GTPases requires prenylation and is dependent on 
two evolutionarily conserved paralogs, Rab escort protein (REP) and RabGDI (8, 31).  
REP presents nascent Rab GTPases to Rab geranylgeranyl transferase (RabGGTase) for 
addition of one or in most cases two 20-carbon prenyl groups and subsequently delivers 
Rab proteins to membranes (32).  Transfer between membranes is facilitated by RabGDI, 
which extracts Rab GTPases after GTP hydrolysis (33), and by GDI displacement factors 
(GDFs), which catalyze release of Rab GTPases from GDI (34).  Crystallographic studies 
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of RabGDI and REP, alone and in complex with prenylated Rab GTPases, have 
delineated common structural features as well as key differences between the two 
proteins in addition to providing detailed snapshots of the protein-protein and protein-
prenyl interfaces (35-40).  RabGDI and REP share a similar overall architecture with two 
domains (Domain I and II) as compared in Figure 1.5A and 1.5B.  Domain I conserves 
several features involved in Rab binding, including the 'Rab-binding platform' that 
interfaces with the switch/interswitch regions, the 'C-terminal binding region' (CBR) that 
engages an aliphatic-X-aliphatic (AXA) motif present in the otherwise hypervariable C-
terminal extension of many Rab proteins, and the 'mobile effector loop' (MEL), which 
also contacts the C-terminal hypervariable extension.  REP engages a subunit of 
RabGGTase exclusively through Domain II (Figure 1.5C).  The ability of REP but not 
RabGDI to bind RabGGTase reflects two non-conservative substitutions in the REP 
binding epitope of Domain II (41). 
 Although both REP and RabGDI have broad Rab specificity, the affinity for Rab 
GTPases varies (42).  These differences evidently contribute to the etiology of 
choroideremia, a retinopathy linked to a loss of function mutation in the REP-1 isoform. 
Two REP isoforms are found in humans and in cells derived from choroideremia patients, 
the majority of Rab27A is unprenylated suggesting that REP-2, which has lower affinity  
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Figure 1.5 Structures of RabGDI and REP complexes with prenylated Rab 
  GTPases or Rab GGTase illuminate the structural mechanisms for 
  membrane targeting. 
(A) Structure of RabGDI in complex with mono-geranyl geranylated Ypt1p.  (B) 
Structure of REP in complex with mono-geranyl geranylated Rab7.  Note overall 
similarity to the RabGDI-Ypt1p complex with respect to the protein-protein interface and 
location of the prenyl binding pocket.  (C) Structure of REP in complex with 
RabGGTase.  Docking of Domain II with the a subunit of RabGGTase orients the Rab 
binding platform in Domain I of REP such that the flexible C-terminus of bound Rab 
GTPases can readily extend to the active site in the β subunit.  Images based on Protein 
Data Bank entries 1UKV (RabGDI•Ypt1), 1VG0 (REP1•Rab7•GDP), and 1LTX 
(REP1•RabGGTase) 
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for Rab GTPases than REP-1, cannot compensate for loss of REP-1 function (43).  The 
underprenylation of Rab27A is likely due to weaker affinity for REP-2 compared with 
other Rab proteins (37).  Finally, it is interesting to note that the known eukaryotic GDFs, 
PRA1 and the yeast ortholog YIP3, are polytypic integral membrane proteins (34).  In 
depth discussion related to membrane targeting by REP, GDI and GDF can be found in 
several reviews (8, 42, 44). 
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Activation by GEFs 
 
 GEFs control GTPase activation by catalyzing the exchange of GDP for GTP.  
This section will start by discussing the complex activation process, which involves 
multiple allosteric changes that can be followed in an interconnected scheme.  After 
discussing the scheme in a cellular context, GEF kinetic terminologies used throughout 
this thesis will be introduced.  Since Arf and Rab GEFs are multi-domain proteins that 
can integrate different cellular signals into the activation process, valuable insights can be 
gained by first discussing the mechanisms through which multi-domain GEFs for other 
small GTPases, such as the Ras GEF Sos, have exploited their various domains to 
coordinate the activation process.  The general precedent for the catalytic domain of 
GEFs to be autoinhibited by another flanking domain will be highlighted together with 
how the domain responsible for autoregulation can also be involved in membrane 
targeting.  Remarkably, some GEFs have tied membrane targeting to relief of 
autoinhibition to allow precise spatial control of activation.  Kinetic analyses of the 
catalytic mechanisms and determination of whether a GEF is indeed autoregulated are 
facilitated by sensitive nucleotide exchange assays.  Hence, different quantitative 
methods for measuring GEF mediated nucleotide exchange will be described next.  
Finally, structural and functional relationship in different Arf and Rab GEFs will be 
discussed. 
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General allosteric activation mechanism 
 As discussed earlier, GTPases mediate multiple interactions with guanine 
nucleotides through the five G motifs and (indirectly) the Mg2+ cofactor.  This extensive 
network of contacts results in very high nucleotide affinity (low nM to pM) and a slow 
intrinsic rate of nucleotide dissociation (hours to days) (45-50).  Kinetic, thermodynamic 
and structural analyses of GEFs for different GTPase families support an allosteric 
competition mechanism for acceleration of nucleotide exchange, whereby GEFs disrupt 
the binding site and compete with nucleotides for binding to GTPases (45, 46, 49, 51).  
This mechanism is depicted in terms of a coupled equilibrium involving the nucleotide 
free (G) and bound (G•GXP) forms of the GTPase, the binary nucleotide free GEF•G 
complex and the ternary GEF•G•GXP complex, where GXP represents GDP or GTP 
(Figure 1.6).   
 Although figure 1.6 shows three theoretical routes through which GEFs can 
engage GTPases, in cells the main reaction pathway for the majority of GEFs is via 
formation of the ternary GEF•G•GDP complex (left hand route).  Direct formation of the 
binary GEF•G complex (middle route) is unlikely to occur in GEF mediated exchange.  
As described earlier, Arf and Rab GTPases have very high nucleotide affinity as well as 
slow off-rates and hence the population of unliganded GTPases is vanishingly small 
under physiological conditions. Direct formation of the ternary complex  
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GDP + G + GTP G•GTP 
+ 
GEF 
+ 
GEF 
GDP + GEF•G + GTP GEF•G•GTP 
G•GDP 
GEF•G•GDP 
+ 
GEF 
Figure 1.6 Kinetic scheme for the interaction of any GEF, GTPase (G) and  
  nucleotide.  
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(right hand route) is also unlikely to occur, as GEFs typically associate slowly with GTP 
bound GTPases.  Moreover, GTP is relatively abundant (200-500 μM) in cells (52) and 
likely exceeds that of the GEF by 100 fold or more.  Hence, the equilibrium is strongly 
shifted in the direction of the GTP bound intermediates. 
 Whereas most GEFs have weak affinity for the GTP bound GTPase (high μM to 
low mM), cellular effectors have substantially higher affinity (high nM to low μM) for 
active GTPases, which may further prevent the reverse reaction (25, 45, 49, 53-55).  
Since cellular conditions favor entry through direct formation of ternary GEF•G•GDP 
complex, the reaction pathway starting from free G•GDP and GEF will be described and 
investigated in this thesis. 
 Several crystal structures of binary nucleotide free Arf- and Rab-GEF complexes 
have been solved, in addition to a few structures of ternary GEF•G•GDP complexes.  The 
details for each complex will be discussed later; however, a unifying theme from these 
structural studies is that GEFs typically bind to the switch regions of GTPases and disrupt 
the base as well as Mg2+/phosphate regions of the binding site to facilitate nucleotide 
egress.  After GDP is released, some GEFs stabilize the nucleotide free state by 
mimicking interactions made by the γ phosphate of GTP.  Consistent with the structural 
observations, thermodynamic and kinetic studies show that the binary nucleotide free and 
GEF•G complex has higher affinity (KD in the low nM range) than the ternary 
GEF•G•GXP complexes (KD in the high μM range), which explains why the binary 
complex can be more readily trapped in a crystalline lattice (45, 46, 49, 51).  The cellular 
GTP concentration is approximately 10 fold higher than that of GDP and likely exceeds 
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that of the GEF by 100 fold or more (56).  Hence, GTP can bind to the binary nucleotide 
free intermediate forming a high energy/low affinity ternary GEF•G•GTP complex which 
dissociates to form the more stable G•GTP state.  Therefore, in a cellular context, the 
predominate GEF mediated activation pathway is effectively G•GDP ⇄ GEF•G•GDP ➝ 
GEF•G ➝ GEF•G•GTP ➝ G•GTP.  
 
GEF kinetics 
 As explained above, GEF mediated nucleotide exchange consists of multiple 
individual steps.  Clever isolation of reaction intermediates together with transient kinetic 
approaches has been used to obtain elementary rate constants.  However, most of these 
reaction intermediates tend to precipitate and are not readily accessible.  Thus, Michaelis-
Menten (rapid equilibrium) and Briggs-Haldane (steady state) kinetic solutions have been 
more widely exploited in the study of GEF:GTPase reaction mechanisms.  In GEF 
kinetics, the turnover number (kcat) corresponds to the maximal GDP release rate constant 
(without excess nucleotide) or to the maximal GDP/GTP exchange rate constant (with 
excess nucleotide) in the limit of saturating [GEF] while the steady state Michaelis 
constant (KM) corresponds to the half maximal [GEF].  Under physiological conditions, 
GDP release is generally thought to be the rate limiting step as discussed in the previous 
section.  One reason why kcat is measured using saturating [GEF] and not saturating 
[G•GDP] (i.e. measured under single turnover conditions) is that GDP is a product 
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released during nucleotide exchange.  Rebinding of released GDP allows futile 
GDP/GDP exchange cycles to compete with the GDP/GTP exchange reaction.  
 Catalytic efficiency (kcat/ KM) represents the catalytic activity of GEFs under 
conditions where the occupation of active site is low and is routinely used to evaluate the 
specificity of GEFs for GTPase substrates and in mutational analyses of catalytic and 
specificity determinants.  The higher the kcat/ KM value, the more efficient the GEF is for 
that substrate.  The catalytic cores of most GEFs have kcat/ KM values ranging from 104 to 
107 M-1 s-1.  GEF:GTPase systems that have catalytic efficiency around 108 M-1 s-1 are 
near the diffusion controlled limit and can be considered kinetically perfect (45, 46, 49, 
51).   
 
Localization and regulation 
 
 Arf and Rab GEFs are typically multi-domain proteins.  Some of the domains are 
required for membrane targeting whereas others mediate intramolecular interactions with 
the catalytic domain or bind to cellular factors including the active forms of Arf or Rab 
GTPases.  As a result, the catalytic output of GEFs can be regulated at multiple levels.  
An effective increase in concentration, and therefore net catalytic turnover, can occur by 
colocalization of GEFs and GTPases on membranes.  Membrane recruitment of GEFs 
depends on protein-protein interaction domains, such as the SH2 and Ras association 
domains in the RIN family of Vps9 domain GEFs for Rab5 subfamily GTPases and/or 
lipid targeting motifs such as pleckstrin homology (PH) domains in several Sec7 domain 
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Arf GEFs or Membrane Occupation and Recognition Nexus (MORN) repeats in Alsin, a 
Vps9 domain Rab5 GEF encoded by the ALS2 gene.  From a kinetic perspective, this 
'restricted volume effect' (also frequently, described as a 'reduction in dimensionality') 
results in a substantially lower apparent KM and a concomitant increase in apparent 
catalytic efficiency (kcat/ KM) with no change in kcat. 
 GEF activity can also be regulated through intramolecular interactions with the 
catalytic domain.  Inhibition of the catalytic domain of GEFs in cis by neighboring 
domains has been documented in many classes of GEFs including the Rab5 GEF Rabex-
5, Rho GEF Vav, Ras GEF Sos, and Rap GEF Epac (57-60).  The most convincing way 
to demonstrate that a GEF is autoregulated is to determine the structure of the 
autoinhibited conformation in conjunction with biochemical and mutational analyses of 
the catalytic efficiency of the catalytic core alone and in the context of the full length 
protein.  Hence, Chapter II will utilize structural, biochemical and mutational approaches 
to investigate an autoinhibitory mechanism in the Cytohesin family of Sec7 domain Arf 
GEFs.   
 Many studies have explored molecular mechanisms for relief of autoinhibition.  
Relief can come from either direct binding to another protein in trans or through post-
translational modification by signaling proteins (e.g. phosphorylation by Tyr or Ser/Thr 
kinases), often creating indirect feedback loops.  For Vav proteins, structural analyses 
showed that the Rho GTPase binding site in the catalytic Dbl homology (DH) domain is 
occluded by an N-terminal extension.  Phosphorylation of the N-terminus by Src- and 
Syk-family kinases displaces the extension (60).  Biochemical and secondary structure 
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analyses suggested that the catalytic core of the Rab5 GEF Rabex-5 is autoinhibited by a 
predicted C-terminal helix; however, the structural basis for autoinhibition and activation 
remain unclear.  Interestingly, the binding of multivalent Rab5 effector Rabaptin-5 to the 
same C-terminal helical region of Rabex-5 stimulates its exchange activity for Rab5 and 
synergistically enhances active Rab5-dependent in vitro fusion (57, 61, 62).  Since 
Rabaptin-5 binds the Rab5-GTP product of Rabex-5, it has been proposed that the initial 
generation of active Rab5 by Rabex-5 or possibly other Vps9 domain GEFs, creates a 
positive feedback loop to recruit additional Rabaptin-5 to a localized micro-domain to 
further stimulate Rabex-5 activity (61).    
 A third mechanism of GEF regulation through unique domain interactions 
involves the use of second messengers such as Ca2+, cAMP and diacylglycerol (DAG) to 
activate GEFs.  The autoinhibited structure of the Rap GEF EPAC2 revealed that its 
catalytic domain is sterically blocked by a N-terminal cyclic nucleotide binding (CNB) 
domain (58).  Binding of cAMP results in an allosteric change in the CNB domain that 
relieves autoinhibition (63).   
 The various mechanisms to modulate GEF activity are not mutually exclusive and 
the Ras GEF Sos is a good example of a protein that uses a multi-faceted approach to 
regulation.  Sos has a molecular architecture consisting of an N-terminal Histone domain, 
a DBL homology (DH) domain, a PH domain, a Ras catalytic domain and a proline rich 
region.  Membrane targeting domains of Sos reduces the apparent KM as mentioned 
earlier, and Sos utilizes multiple mechanisms to target the membrane: non-specific 
electrostatic interaction of the Histone domain, lipid binding via the PH domain, and 
 26 
binding of the proline rich region to the SH3 domain of the adaptor protein Grb2 (64-68).  
Also, the catalytic C2DC5 domain of Sos is autoinhibited by both the Histone domain 
and DH-PH tandem (59, 69).  Membrane targeting through the Histone and PH domain 
only partially relieves autoinhibition (70).  The catalytic domain of Sos is further 
allosterically activated by Ras-GTP through an allosteric site distal to the active site (71).  
In cells, the concentration of Ras-GTP is likely controlled by both a positive and negative 
feedback loops.  Indeed, Ras-GTP allosterically activates Sos but also results in the 
activation of the effector Erk kinase, which phosphorylates Sos.  Phosphorylated Sos has 
reduced affinity for Grb2 resulting in membrane dissociation (68).  
 
Methods for measuring nucleotide exchange 
 Historically, the most commonly used method of measuring GEF stimulated 
nucleotide exchange was by a filter binding assay that monitored loading of radiolabeled 
nucleotides (this is commonly referred as radioactive filter binding assay).  In this assay, 
one mixes the GEF, GTPase and radiolabeled GTP and takes out aliquots of the reaction 
mixture to be placed on filter paper at different time points.  The filter paper traps the 
GTPase and bound radiolabeled GTP, which is quantified by scintillation counting.  This 
assay proved useful for identification of many early novel GEF proteins but can only 
provide limited detail on the potential capacity for nucleotide binding and does not have 
the sensitivity to discriminate amongst closely related substrates.  
 In this thesis, three quantitative fluorescence approaches are utilized for the 
continuous measurement of nucleotide exchange.  Each method has distinct advantages 
 27 
but all can in principle measure the same rate-limiting GDP release rate under appropriate 
experimental conditions as discussed in detail in Chapter III.  The first approach makes 
use of methylanthraniloyl (mant) fluorophore conjugated to the 2' and/or 3' hydroxyl 
group of GDP (mant-GDP) as the bound nucleotide and monitors its release from the 
GTPase as a 2-3 fold decrease in emission intensity.  The main advantage of mant-GDP 
is that it has an excitation wavelength where protein absorbance and excitation of 
intrinsic fluorophores is relatively low.  Hence, one usually does not need to worry about 
inner filter effects or background fluorescence when measuring kcat.  One drawback with 
this approach is that the mant group has been demonstrated to mediate non-polar contacts 
with at least some GTPases and can affect the rate of both intrinsic and GEF-facilitated 
exchange (50, 72).   
 The second approach takes advantage of differences in the local environment of 
tryptophan residues in the active and inactive states of the GTPase by monitoring the 
change in intrinsic tryptophan fluorescence intensity upon exchange of bound nucleotide.  
This method has the advantage of measuring the rate of unlabeled GDP to GTP 
exchange, which is often indistinguishable from the rate of mant-GDP release.  However, 
one potential hurdle in these experiments is that the conformation of the tryptophan is 
also affected by the Mg2+ cofactor.  Thus, the total tryptophan fluorescence could reflect 
both GEF mediated Mg2+ disruption and nucleotide exchange. 
 An alternative approach that measures only the rate of nucleotide binding and not 
GEF mediated Mg2+ disruption is to monitor fluorescence resonance energy transfer 
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(FRET) from donor tryptophan residues to mant-GTP.  The drawback in this method is 
that mant-GTP is very expensive and is impractical to use at very high concentrations. 
 In all three approaches, experiments are usually conducted with a large excess of 
the displacing nucleotide and a low concentration of GTPase to ensure that the exchange 
reactions proceed under single turnover conditions with the bimolecular events well 
represented by the psuedo-first order approximation.  Since GTP can by hydrolyzed by 
the GTPase, a non-hydrolyzable analog GppNHp is used in all assays.  
 
Arf GEFs 
 Arf GEFs contain a catalytic Sec7 domain that is homologous to the yeast protein 
Sec7p, which was identified in a screen for protein secretion defects.  There are ~15 
mammalian Sec7 domain containing proteins, which are classified into five families 
based on their domain structure: FBX08, Cytohesins, EFA6, BRAGs and GBF/BIG 
(Figure 1.7).  
 FBX08 is the smallest and least characterized Arf GEF.  It is distinguished by an 
Fbox motif N-terminal to the Sec7 domain.  The Fbox motif may mediate Arf6 
ubiquitination by interaction with E3 ligases (73).  
 The Cytohesin family of GEFs includes Cytohesin-1, Cytohesin-2/ARNO, 
Cytohesin-3/Grp1 and Cytohesin-4.  These four proteins are characterized by an N-
terminal heptad repeats, a Sec7 domain, a pleckstrin homology (PH) domain, and a C-
terminal polybasic sequence.  The N-terminal heptad repeats can homodimerize or 
heterodimerize with the heptad repeats of GRP1 signaling partner 1 (Grsp1) (74, 75). The  
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Figure 1.7 Domain architecture for a single representative of each of the five 
  families of Sec7 domain proteins found in humans.   
CC, Coiled coil; DCB, dimerization and cyclophilin binding; HDS, homology 
downstream of Sec7; HUS, homology upstream of Sec7; IQ, IQ motif; PH, pleckstrin 
homology domain 
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significance of the homo or heterodimer is unclear and little is known about Grsp1 except 
that it contains a N-terminal 4.1 protein/ezrin/radixin/merlin (FERM) homology domain 
in addition to 2 possible coiled coil motifs (75).  Using a filter binding assay, the isolated 
Sec7 domain was found to accelerate GTPγS binding to a greater extent than the full-
length protein and to act preferentially on Arf1 (76-78).  Localization of Grp1 family 
proteins to the plasma membrane involves both the PH domain as well as the polybasic 
sequence and subsequent activation of Arfs have been implicated in a variety of cellular 
processes including adhesion, endocytic trafficking, cell motility, T-cell anergy, helper T-
cell activation, and insulin signaling (79, 80).  
 The IQSEC/BRAG family of Arf GEFs includes IQSEC1/BRAG2/GEP100, 
ISQC2/BRAG1 and IQSEC3/BRAG3.  These three proteins share a common domain 
organization consisting of an IQ-like domain, a Sec7 domain and a PH domain. 
Canonical IQ domains can bind calmodulin, but whether this function is conserved in all 
IQSEC GEFs has not been investigated.  The Sec7 domain of IQSEC1 was shown to 
have preference for the class III Arf6 in a filter binding assay (81).  Interestingly, 
IQSEC1 is implicated in tumor invasion and metastasis through Arf6 activation and PH 
domain dependent EGFR signaling (73).  However, more quantitative and direct 
biochemical analyses are needed to support the idea of the IQSEC1 PH domain binding 
directly and specifically to the EGFR receptor.  
 The EFA6 family of GEFs includes four members named EFA6A-D.  They have 
a modular architecture consisting of a variable N-terminal region, a central Sec7 domain, 
a PH domain and a C-terminal coiled coil motif.  Quantitative nucleotide exchange assays 
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show that the isolated Sec7 domain of EFA6 at 0.8 μM can accelerate nucleotide 
exchange on Arf6 up to 8 fold but has little acceleration on Arf1 (76).  Localization of 
EFA6 to the plasma membrane via the PH domain and subsequent activation of Arf6 has 
been implicated in tight junction maintenance in MDCK cells (82).  
 GBF1 and BIG1/2 can be classified in the same phylogenetic family, as they have 
the same modular architecture of an N-terminal dimerization and cyclophilin binding 
motif (DCB), Homology Upstream of Sec7 (HUS) domain, central Sec7 domain and 
three additional Homology Downstream of Sec7 (HDS) domains.  However, many 
functional differences are found between GBF1 and BIG1/2.  GBF1 is localized to the 
early Golgi compartment but Big1/2 is localized to the trans Golgi compartment (83).  
Filter binding assays also suggest that the Sec7 domain of BIG1/2 has the highest activity 
on the class I Arf1 but GBF1 has highest activity on the class II Arf5 (84, 85).   
 The fungal toxin brefeldin A (BFA) is commonly known for its ability to disrupt 
the Golgi morphology by inhibiting the activation of Class I and II Arfs but not the class 
III Arf6 (86, 87).  Surprisingly, BIG1 and BIG2 are the only BFA-sensitive Sec7 GEFs 
even though GBF1 shares high homology with them (84).  BFA (colored magenta) 
inhibits Arf activation through an uncompetitive mechanism by binding at the interface 
between the low affinity BIG1/2 Sec7 domain•Arf•GDP complex and stabilizing it in a 
high affinity conformation to prevent GDP dissociation (Figure 1.8A) (88).  
 32 
 
 
Figure 1.8 Structural mechanism for activation of Arf GTPases by Sec7 domains. 
(A) Sec7•BFA•Arf1•GDP complex.  BFA (magneta) binds to both the Sec7 domain 
(slate) and the β2-β3 interswitch regions of Arf1 (yellow).  (B) Nucleotide free 
Sec7•Arf1 complex.  The Sec7 catalytic core accelerates GDP release on Arf GTPase by 
supplying a 'glutamate finger' (red) to destabilize GDP (panel A, marine)/Mg2+(panel C, 
pink) binding and stabilize a collapsed P-loop conformation through interaction with an 
invariant lysine residue (green).  (C) Arf1•Mg2+•GTP.  Images based on unreleased 
coordinate from Jonathan Goldberg (Sec7•Arf1) and Protein Data Bank entries 1RE0 
(Sec7•BFA•Arf1•GDP), and 1O3Y (Arf1•Mg2+•GTP)   
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 Sequence differences between BIG1/2 and other GEFs like Cytohesins helps 
explain the fact that BFA exclusively targets BIG1/2.  Four residue differences (Phe 190, 
Ala 191, Ser 198 and Phe208) in the Cytohesin-2/ARNO Sec7 domain are responsible for 
the full BFA insensitivity (89, 90).  Remarkably, replacing only Phe190 with a Tyr that as 
found in the Big1/2 Sec7 domain is sufficient to make Cytohesin-2 BFA sensitive (86).  
In the inactive Arf1•Sec7•BFA complex, Tyr from the Sec7 domain forms a crucial 
hydrogen bond with hydroxyl group7 from BFA.  As predicted from this structural 
analysis, a version of BFA that lacks the hydroxyl group7 has lower affinity for the 
ternary Sec7•Arf1•GDP complex.  
 The structure of the ternary complex trapped by BFA allows comparison with 
structures of inactive Arf1, the binary nucleotide free Sec7•Arf1 complex and Arf1•GTP 
to provide an atomic view of the nucleotide exchange process (Figure 1.8) (17, 29, 88, 
91). The Sec7 domain has a single elongated fold with 10 α helices, and there will be a 
constant referral to an invariant glutamic acid residue (Figure 1.8-colored red) commonly 
known as the 'glutamate finger', which is crucial in mediating nucleotide exchange.  
Comparison of Arf1•GDP alone and with the Sec7•BFA•Arf1•GDP complex shows little 
deviation.  The interswitch region has not undergone the toggling to extrude the N-
terminal helix but has a slight opening in the β2-β3 strands fastened by BFA.  The β2-  
β3 cavity is not caused by BFA and is induced by the Sec7 domain when it utilizes a 
hydrophobic groove to dock onto the two switch and interswitch regions.  The main 
evidence supporting this claim is that the opening is also found in other Sec7•Arf1 
complexes without BFA.  Interestingly, in this stable Sec7•BFA•Arf1•GDP complex, the 
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conserved 'glutamate finger' that is required for subsequent expulsion of Mg2+ and GDP 
(Figure 1.8A- colored marine) is far from the active site and helps to explain why GDP is 
not released in this complex.  
 The structure of the nucleotide free Sec7•Arf1 complex has offered an 
understanding of the molecular mechanism by which the Sec7 domain catalyzes GDP 
release.  In this structure the Sec7 domain has rearranged the two switch and interswitch 
regions to the active conformation destroying the docking site for the N-terminal helix 
(Figure 1.8B) (92).  In addition, the P-loop is distorted into a conformation that prevents 
binding of the β-phosphate but leaves the guanine binding site available.  This is 
achieved through insertion of a wedge of conserved hydrophilic amino acids (GES/AQ) 
into the Mg2+/phosphate binding site by the Sec7 domain.  Notably, the 'glutamate finger' 
not only occupies the Mg2+ binding site but also stabilizes a collapsed P-loop through 
interaction with the invariant P-loop lysine (Figure 1.8- colored green), which also binds 
to the β and γ phosphates of bound nucleotides.  
 
Rab GEFs 
 Unlike Arfs GEFs, which can be identified by a single conserved domain, there 
are multiple Rab GEF domains with very different sequences. These Rab GEFs are 
structurally diverse, ranging in size and complexity from small proteins to large modular 
proteins and multiprotein complexes. As such, despite a common underlying reaction 
mechanism, Rab GEFs exhibit a broad range of catalytic efficiencies and substrate 
specificities, differ markedly regarding recognition of GDP- vs. GTP-bound 
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conformations, and are subject to distinct intramolecular and intermolecular mechanisms 
for regulation of catalytic output.  Figure 1.9 shows some of the structures of the catalytic 
cores these Rab GEFs in complex with the target Rab GTPases.  Discussed below, these 
studies illustrate the remarkable degree to which Rab GEFs have evolved not only to 
recognize different Rab substrates but also to facilitate nucleotide exchange through 
largely unrelated structural mechanisms. 
 The 17 kDa protein Mss4 and its yeast ortholog Dss4 were amongst the first Rab 
GEFs identified.  Mss4 has weak exchange activity and an atypical ability to recognize 
both GDP- and GTP-bound forms of several exocytic Rab GTPases from different PGs, 
including Rab1/Ypt1p, Rab3, Rab8/Sec4p and Rab10 (46, 93, 94).  As these Rab 
GTPases have other GEFs with higher catalytic efficiencies, Mss4/Dss4 have been 
suggested to function in vivo as molecular chaperones for nucleotide free Rab GTPases 
(94, 95).  The structure of the nucleotide free Mss4-Rab8 complex (Figure 1.9A) 
indicates that Mss4 interacts with the N-terminal complementary determining region 
(CDR), switch I, and the interswitch region, promoting nucleotide release by an indirect 
mechanism whereby Mss4-induced rearrangement of switch I causes the α1 helix to 
unfold (94). 
 Compared with Mss4/Dss4p, Sec2p has 100-1000 fold higher exchange activity 
for Sec4p, and yet the exchange domain in Sec2p is a deceptively simple asymmetric 
coiled coil.  Sec2p engages the switch and interswitch regions of Sec4p (Figure 1.9B) and 
simultaneously displaces Sec4p's N-terminus from the base region of the nucleotide while   
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Figure 1.9 Structures of GEFs in complex with nucleotide free Rab GTPases  
  suggest largely distinct structural mechanisms for catalysis of   
  nucleotide exchange.   
(A) Mss4 promotes nucleotide release by a local unfolding mechanism in which switch I 
of Rab8 is contorted into a conformation that forces unfolding of the α1 helix.  (B) The 
Sec2p catalytic core is an asymmetric coiled coil that indirectly facilitates nucleotide 
release by stabilizing switch I of Sec4p in a conformation that conflicts with nucleotide 
binding.  (C) The Rabex-5 catalytic core accelerates nucleotide exchange on Rab5 and 
Rab21 by supplying an 'aspartate finger' to destabilize Mg2+/GDP binding and 
subsequently stabilize the nucleotide free intermediate through interactions that mimic 
the γ phosphate of GTP.  (D) The multi-subunit catalytic core of yeast TRAPPI relies on 
the C-terminus of Bet3p to stimulate GDP release from Ypt1p and stabilize the 
nucleotide free conformation.  Images based on Protein Data Bank entries 2FU5 
(MSS4•Rab8), 2OCY (Sec2p•Sec4p), 2OT3 (Rabex-5•Rab21), and 3CUE 
(Ypt1p•TRAPPI).  
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forcing an isoleucine from the C-terminus into the Mg2+/phosphate binding region (96, 
97).  Interestingly, Rabin8 and Rab8 (the mammalian orthologs of Sec2p and Sec4p, 
respectively) are associated with Bardet-Biedl syndrome (BBS), a genetic disorder whose 
symptoms include obesity, retinal degeneration, and nephropathy (98-100).  Rabin8 is 
required for targeting of Rab8 to the primary cilium and disruption of Rab8 in Zebrafish 
results in BBS phenotypes (100). 
 Defined by homology with yeast Vps9p, which was identified in a screen for 
vacuolar protein sorting defects, the Vps9 domains of ten modular mammalian proteins 
facilitate nucleotide exchange by a mechanism similar to Sec7 domains (101, 102).  The 
best characterized Vps9 domain protein Rabex-5, forms an endogenous complex with 
Rabaptin-5 (62), and cooperates with other factors to promote endosome fusion (61, 62, 
103, 104).  Rabex-5 catalytic core consists of a helical bundle (HB)-Vps9 domain tandem 
with equivalently high exchange activity for the PG5 Rab GTPases Rab5 and Rab21 (62, 
102).  The N-terminal HB makes stabilizing interaction with the Vps9 domain but does 
not come into direct contact with Rab21.  In the structure of the Rabex-5 HB-Vps9 
tandem in complex with nucleotide free Rab21 (57), invariant aromatic residues from the 
switch and interswitch regions of Rab21 dock in a non-polar groove between adjacent 
helices in the Vps9 domain (Figure 1.9C).  An invariant 'aspartate finger', analogous to 
the 'glutamate finger' in the Sec7 domain, stabilizes the nucleotide free intermediate by 
mimicking interactions of the γ phosphate with the invariant P-loop lysine and switch II 
backbone.  Comparison with the structures of the HB-Vps9 tandem alone and nucleotide-
bound forms of Rab21 suggests that the aspartate finger promotes GDP release through 
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disruption of the Mg2+ binding site.  The Vps9 and Sec7 domains also facilitate 
nucleotide egress by propping switch I in an open/flexible conformation (29, 88, 102).  
Finally, in contrast to Mss4/Dss4p, the weak exchange activity of full length Rabex-5 
(46) is not a property of the catalytic core but instead reflects potent autoinhibition by a 
helical region C-terminal to the Vps9 domain (57). 
 Transport protein particle I (TRAPPI) activates Ypt1p/Rab1 during COPII-vesicle 
tethering (105, 106).  Unlike most GEFs, the catalytic core of TRAPPI consists of four 
proteins with a stoichiometry of 2 Bet3p to 1 each of Bet5p, Trs23p and Trs31p (107).  
Structures of Bet3p alone and two catalytically inactive subcomplexes of mammalian 
TRAPPI revealed the overall architecture as well as a common α/β fold shared by the 
small subunits (107, 108).  Insight into the exchange mechanism was provided by the 
structure of the yeast TRAPPI catalytic core in complex with nucleotide free Ypt1p 
(109).  Residues from Trs23p, Bet5p and the C-terminus of Bet3p engage the β1 strand, 
switch, interswitch, and P-loop regions of Ypt1p (Figure 1.9D).  Trs31p interacts with 
Bet3p and Trs23p but does not contact Ypt1p directly; nevertheless, comparison with the 
inactive subcomplexes lacking Trs23p reveals a conformational change in Trs23p that 
propagates to the interface with Ypt1p.  Although a glutamate from Bet3p appears to 
stabilize the nucleotide free conformation of the P-loop, double alanine substitution of 
this residue and an adjacent aspartate has a relatively modest (5 fold) effect on the 
exchange activity.  This contrasts with much larger effects (100 fold) for alanine 
substitution of the asaprtate and glumatate fingers in the Vps9 and Sec7 domains (102, 
110).  Evidently, elements outside of those originally hyposthesized account for much of 
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the observed 400 fold acceleration of GDP release by wild type TRAPPI.  Most notably, 
the C-terminus of one Bet3p subunit intrudes into the nucleotide binding pocket, 
suggesting a role in stabilization of the nucleotide free intermediate and/or acceleration of 
GDP release through interaction with switch I.  Consistent with this hypothesis, deletion 
of the Bet3p C-terminus reduces exchange by ~2 orders or magnitude.  Further discussion 
of TRAPPI/II complexes can be found in recent reviews (2, 111). 
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Catalytic and autoinhibitory mechanisms in Sec7 and Vps9 domain 
exchange factors 
 The structural basis for how the isolated catalytic Sec7 and Vps9 domains activate 
Arf and Rab GTPases through an acidic finger to disrupt the Mg2+/phosphate binding site 
has been examined in detail.  However, full-length Sec7 and Vps9-containing proteins 
have multiple domains that could modulate the catalytic activity.  Qualitative experiments 
suggested that the exchange activity of full length Cytohesin-1 is weak compared to the 
isolated Sec7 domain (77).  To gain insight into the weak exchange activity of full length 
Cytohesin family of GEFs, chapter II of this thesis exploits quantitative fluorescence 
approaches that had been described in the GEF section to measure the catalytic efficiency 
of the isolated Sec7 domain and the full length proteins in the Cytohesin family of Arf 
GEFs.  Molecular biology, protein biochemistry and GEF assays were used to identify 
the regions in the Cytohesins that are responsible for the weak exchange activity.  An 
autoinhibited crystal structure of Grp1/Cytohesin-3 revealed that two areas outside of the 
catalytic Sec7 domain block the binding to inactive Arf GTPases.  Autoinhibition was 
found to be partially relieved in two non-exclusive ways: through the binding of active 
Arf6 and Ins(1,3,4,5)P4 to Cytohesin-1 and/or phosphorylation of tandem PKC sites in 
the polybasic motif of Cytohesin-1. 
 Full length Cytohesin-1 and Rabex-5 are autoinhibited by intramolecular 
interactions with elements beyond the catalytic core.  To gain insight into the kinetic 
properties independent of autoregulatory elements, Chapter III describes detailed stopped 
flow kinetic analysis using the isolated catalytic cores of Cytohesin-1 and Rabex-5.  
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Taking advantage of three complementary fluorescence methods to monitor Mg2+ 
dissociation, formation of the nucleotide free intermediate, and subsequent nucleotide 
binding, the catalytic cores of Cytohesin-1 and Rabex-5 were found to robustly accelerate 
nucleotide exchange on Arf1 and Rab5 respectively, by at least 105 fold at physiological 
concentrations of Mg2+.  In addition, both of these GEF cores have similar catalytic 
efficiencies for cognate GTPase substrates and the highest KM and kcat values examined 
to date.  The high KM values are consistent with the observations that these GEFs are 
membrane targeted and favors robust spatial-temporal control over catalytic output.  
However, GDP release is accelerated to a lesser extent at low Mg2+ levels, suggesting 
that disruption of the Mg2+ binding sites contributes to the rate limiting steps for 
nucleotide release.  
 This chapter contains work previously published in Lee, et al. 2009. (14).  The 
review on the regulation of membrane traffic by Rab GTPases is coauthored by David 
Lambright, Ashwini Mishra and myself.  Ashwini Mishra and David Lambright helped to 
make some of the figures.   
  
 42 
CHAPTER II 
 
Mechanism of Autoregulation in 3-Phosphoinositide 
Dependent Cytohesin Family Arf GTPase Exchange Factors 
 
Summary 
 Arf GTPases regulate membrane trafficking and actin dynamics.  Cytohesin-1, 
ARNO and Grp1 comprise a family of phosphoinositide-dependent Arf GTPase exchange 
factors with a Sec7-pleckstrin homology (PH) domain tandem.  Here we report that the 
exchange activity of the Sec7 domain is potently autoinhibited by conserved elements 
proximal to the PH domain.  The crystal structure of the Grp1 Sec7-PH tandem reveals a 
pseudo-substrate mechanism of autoinhibition in which the linker region between 
domains and a C-terminal amphipathic helix physically block the docking sites for the 
switch regions of Arf GTPases.  Mutations within either element result in partial or 
complete activation.  Critical determinants of autoinhibition also contribute to insulin 
stimulated plasma membrane recruitment.  Autoinhibition can be largely reversed by 
binding of active Arf6 to Grp1 and by phosphorylation of tandem PKC sites in 
Cytohesin-1.  These observations suggest that Cytohesin family GEFs are autoregulated 
by mechanisms that depend on plasma membrane recruitment. 
 This chapter contains work previously published in in DiNitto, et al.  2007. (112).  
Jonathan P. DiNitto carried out most of the experimental work.  Meng-tse Lee 
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crystallized and solved the autoinhibited structure of Grp163–399 with a single K68A 
mutation.   
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Introduction 
 Arf GTPases function in vesicular trafficking and cytoskeletal dynamics by 
cycling between active (GTP-bound) and inactive (GDP-bound) conformations (113-
115).  Conversion to the active state is tightly regulated by guanine nucleotide exchange 
factors (GEFs).  Arf GTPases are N-terminally myristoylated, a modification required for 
membrane localization (26-28, 116).  Arf1 is recruited to the Golgi and trans Golgi 
network (TGN) by a switching mechanism that exposes the myristoylated N-terminus 
(92, 117).  Subsequent interactions with COPI coat proteins or clathrin adaptors initiate 
vesicle budding (118, 119).  Arf6 localizes to the plasma membrane in both GDP- and 
GTP-bound conformations (19, 120).  Both Arf1 and Arf6 activate phospholipase D (121, 
122) and phosphatidylinositol (4) phosphate 5-kinase (123).  Arf6 also regulates actin 
remodeling (124, 125), endocytosis (126) and cytokinesis (127, 128). 
 Arf GEFs possess a catalytic Sec7 domain homologous to the yeast Sec7 protein, 
which is essential for intra-Golgi transport (129).  A subset of Sec7 domain GEFs are 
inhibited by Brefeldin A (BFA), which binds at the interface of the Sec7 domain complex 
with Arf1-GDP (90, 130).  The BFA sensitive GEFs Sec7p and Gea1p/Gea2p, and their 
mammalian homologous BIG1/BIG2 and GBF1, activate Arf1 at the Golgi and TGN, 
respectively (83, 131).  The mammalian proteins Cytohesin-1, ARNO/Cytohesin-2 and 
Grp1/Cytohesin-3 represent a subfamily of BFA insensitive GEFs consisting of heptad 
repeats, a Sec7 domain, a PH domain and a polybasic motif (132-134).  All three proteins 
are recruited to the plasma membrane in response to receptor stimulation (134-137).  
Plasma membrane recruitment requires phosphoinositide 3-kinase (PI3K) activity and 
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depends on the PH domain, which binds phosphatidyl inositol (PtdIns) 3,4,5-
trisphosphate (138-140).  Cytohesin family GEFs have been implicated in actin dynamics 
(141, 142), receptor endocytosis (143) and insulin signaling (144, 145). 
 Within the Cytohesin family, diglycine (2G) and triglycine (3G) splice variants, 
differing only in the number of glycine residues in the β1/ β2 loop of the PH domain, 
strongly influence the affinity and specificity for phosphoinositides (146, 147).  Whereas 
the 2G variants selectively bind PtdIns(3,4,5)P3 with high affinity, the 3G variants bind 
PtdIns(3,4,5)P3 with ~30 fold lower affinity and require the polybasic region for plasma 
membrane targeting (137, 148, 149). 
 Crystallographic studies of Sec7 and PH domains alone and in complex with Arf 
GTPases, Brefeldin A and inositol polyphosphates have provided detailed insights into 
the exchange reaction intermediates (29, 88, 91, 92, 150) and determinants of 
phosphoinositide recognition (147, 151-153).  Although little is known regarding the 
structural organization or functional coordination of the modular domains in Arf GEFs, 
the exchange activity of full length Cytohesin-1 is weak compared to the isolated Sec7 
domain (77), suggesting that Arf GEFs may be autoregulated as observed for Ras and 
Rho family GEFs (59, 60, 71, 154, 155).  Here we show that Cytohesin family GEFs are 
autoinhibited by a pseudosubstrate mechanism, which can be partially reversed by 
binding to the active form of Arf6 or by phosphorylation of protein kinase C (PKC) sites 
in Cytohesin-1. 
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Results 
The polybasic motif suppresses exchange activity 
 The catalytic efficiency of a Grp1 construct extending from the N-terminal heptad 
repeats through the C-terminus is ~2 orders of magnitude lower than that of the isolated 
Sec7 domain (Figure 2.1 and Table 2.1-2.2).  Given that this construct purifies as a 
homodimer whereas the Sec7 domain is monomeric, it is possible that the weak exchange 
activity is a consequence of dimerization.  To address this issue and identify potential 
autoinhibitory elements, catalytic efficiency and oligomeric state were determined for 
truncation constructs of Cytohesin family GEFs.  Although truncation of the heptad 
repeats eliminates dimerization, catalytic efficiency is not substantially affected.  
Conversely, truncation of the polybasic motif increases catalytic efficiency by 20-100 
fold but has no effect on oligomeric state.   
 Grp1 forms an endogenous complex with Grsp1, which contains a FERM domain, 
heptad repeats and a serine/threonine rich region (75).  The Grsp1 FERM domain 
conserves acidic residues that, in some FERM domains, interact with polybasic motifs 
(156, 157).  We therefore examined the catalytic efficiency of Grp1 in complex with a 
Grsp1 construct that includes the FERM domain and heptad repeats required for binding 
to the heptad repeats in Grp1.  This construct equilibrates with Grp1 homodimers to yield 
a uniform heterodimeric complex but has little effect on the catalytic efficiency (Figure 
2.1 and Table 2.1-2.2) (74).  Furthermore, the Grsp1 FERM domain does not appear to 
associate with a fluorescein-labeled peptide corresponding to the polybasic  
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Figure 2.1 Cytohesin family Arf GEFs are autoinhibited by the polybasic motif 
(A) Representative time courses for NΔ17Arf1 nucleotide exchange catalyzed by Grp1 
constructs including (green) or lacking (blue) the polybasic motif.  (B) Concentration 
dependence of the observed rate constant for NΔ17Arf1 nucleotide exchange catalyzed 
by Grp1 constructs including (green) or lacking (blue) the polybasic motif.  (C) Summary 
of catalytic efficiencies (kcat/ KM) and oligomeric state for Grp1, ARNO, and Cytohesin-1 
constructs and Grp1-Grsp1 complexes.  Oligomeric state was determined by 
sedimentation equilibrium at concentrations of 4.5-37 mM. 
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Table 2.1 Catalytic efficiency of Cytohesin family constructs and complexes for 
  NΔ17Arf1 
NΔ17Arf1 
Protein Construct kcat/KM (104 M-1s-1) kcat/KM (Arb. Units) 
Grp1 
Sec7 8.0 ± 1.3 78 ± 12 
Sec7-PH 7.6 ± 0.43 74 ± 4.1 
Sec7-PH-pb 0.1 ± 0.003 1.0 ± 0.1 
hr-Sec7-PH 4.7 ± 0.57 45 ± 5.5 
hr-Sec7-PH-pb 0.25 ± 0.093 2.4 ± 0.9 
ARNO 
Sec7 33 ± 1.4 230 ± 9.7 
Sec7-PH 16 ± 0.72 110 ± 4.9 
Sec7-PH-pb 0.15 ± 0.004 1.0 ± 0.1 
hr-Sec7-PH 2.3 ± 0.06 16 ± 0.4 
hr-Sec7-PH-pb 0.082 ± 0.004 0.56 ± 0.1 
Cytohesin-1 
Sec7 18 ± 0.78 89 ± 3.8 
Sec7-PH 14 ± 0.91 73 ± 4.4 
Sec7-PH-pb 0.2 ± 0.01 1.0 ± 0.1 
hr-Sec7-PH 3.2 ± 0.06 16 ± 0.3 
hr-Sec7-PH-pb 0.061 ± 0.024 0.3 ± 0.1 
Grp1-Grsp1 
complex (-IP4) 
hr-Sec7-PH/FERM-hr 3.5 ± 0.41 36 ± 4.2 
hr-Sec7-PH-pb/FERM-hr 0.098 ± 0.030 1.0 ± 0.1 
Grp1-Grsp1 
complex (+IP4) 
hr-Sec7-PH/FERM-hr 5.0 ± 0.30 11 ± 3.0 
hr-Sec7-PH-pb/FERM-hr 0.47 ± 0.038 1.0 ± 0.1 
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Table 2.2 Catalytic efficiency of Cytohesin family constructs and complexes for 
  NΔ12Arf6 
NΔ12Arf6 
Protein Construct kcat/KM (104 M-1s-1) kcat/KM (Arb. Units) 
Grp1 
Sec7 0.28 ± 0.029 24 ± 2.5 
Sec7-PH 0.64 ± 0.025 54 ± 2.1 
Sec7-PH-pb 0.012 ± 0.001 1.0 ± 0.1 
hr-Sec7-PH 0.7 ± 0.029 60 ± 2.4 
hr-Sec7-PH-pb 0.013 ± 0.001 1.1 ± 0.1 
ARNO 
Sec7 6 ± 0.19 32 ± 1.0 
Sec7-PH 4.2 ± 0.07 22 ± 3.8 
Sec7-PH-pb 0.19 ± 0.015 1.0 ± 0.1 
hr-Sec7-PH 1.2 ± 0.099 6.5 ± 0.5 
hr-Sec7-PH-pb 0.073 ± 0.008 0.4 ± 0.1 
Cytohesin-1 
Sec7 3 ± 0.46 32 ± 4.8 
Sec7-PH 3.2 ± 0.11 34 ± 1.2 
Sec7-PH-pb 0.095 ± 0.005 1.0 ± 0.1 
hr-Sec7-PH 0.95 ± 0.035 10 ± 0.3 
hr-Sec7-PH-pb 0.032 ± 0.003 0.3 ± 0.1 
Grp1-Grsp1 
complex (-IP4) 
hr-Sec7-PH/FERM-hr 0.43 ± 0.002 12 ± 0.1 
hr-Sec7-PH-pb/FERM-hr 0.036 ± 0.003 1.0 ± 0.1 
Grp1-Grsp1 
complex (+IP4) 
hr-Sec7-PH/FERM-hr 0.49 ± 0.005 14 ± 0.1 
hr-Sec7-PH-pb/FERM-hr 0.036 ± 0.001 1.0 ± 0.1 
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motif as detected by fluorescence anisotropy nor does it co-precipitate with a GST-fusion 
spanning the PH domain and polybasic motif (data not shown). 
 Given that plasma membrane recruitment depends on the interaction of the PH 
domain with PtdIns(3,4,5)P3, we also tested whether head group binding influences 
catalytic efficiency, possibly through a conformational change analogous to that 
described for the Akt PH domain (158, 159).  Although the head group binds with high 
affinity (Figure 2.2), it has no effect on the exchange activity (Table 2.1).  Considered 
together, these observations indicate that Grp1, ARNO and Cytohesin-1 are strongly 
autoinhibited through an intramolecular mechanism that requires the polybasic motif. 
 
Structure of the autoinhibited Sec7-PH-polybasic region of Grp1 
 To gain insight into the domain organization and structural basis of autoinhibition, 
we conducted crystallization screens with full length Grp1, ARNO and Cytohesin-1 as 
well as constructs lacking the polybasic motif, the heptad repeats, or both.  ARNO and 
Cytohesin-1 constructs lacking the heptad repeats crystallized in complex with 
Ins(1,3,4,5)P4 but diffracted poorly.  An analogous Grp1 construct in complex with 
Ins(1,3,4,5)P4 yielded crystals that diffracted anisotropically to ~3 Å.  Although without 
effect on the exchange activity, the mutation of a disordered surface lysine to alanine 
(K68A) resulted in crystals that diffracted uniformly with two molecules in the 
asymmetric unit.  The structure of the Grp1 K68A mutant in complex with Ins(1,3,4,5)P4 
was solved and refined to 2.1 Å (Figure 2.3-2.5; Table 2.3). 
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Figure 2.2 Affinity of Ins(1,3,4,5)P4 for Grp1 and the Grp1-Grsp1 complex  
  analyzed by isothermal titration microcalorimetry 
Samples of Grp113-399 (10 mM) or the Grp113-399-Grsp12-400 complex (10 mM) were 
titrated with Ins(1,3,4,5)P4.  Raw data were corrected for baseline drift and the total heat 
released during each injection determined by integrating over the injection period.  
Dissociation constants (Kd) were determined by fitting to a 1:1 binding model as 
described in Cronin et al. (2004) EMBO J. 23: 3711-3720. 
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Figure 2.3 Structural organization of an autoinhibited Grp1 construct 
(A) Ribbon rendering showing the Sec7 domain (blue), linker (red), PH domain (green), 
and C-terminal helix (orange).  Ins(1,3,4,5)P4 is represented by red spheres (oxygen 
atoms) and yellow spheres (carbon and phosphate atoms).  (B) Annotated sequence 
alignment of Grp1 family paralogs/homologs. 
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Figure 2.4 Experimental electron density for functionally relevant regions of the  
  Grp163-399 K68A/H260Y mutant. 
σA weighted 2wFo-DFc maps were calculated with phases derived from a 3 wavelength 
MAD experiment and improved by solvent flipping.  The maps include data from 20-1.95 
Å and are contoured at 1.0 σ. 
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Figure 2.5 Simulated annealing omit maps for functionally relevant regions of  
  the Grp163-399 K68A mutant. 
The final refined model is shown with the electron density from σA weighted 2Fo-Fc 
maps following simulated annealing with the linker or C-terminal helix omitted.  Maps 
include data from 20.0-2.0 Å and are contoured at 1.0 σ. 
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Table 2.3 Grp1 Structure Determination and Refinement                                  
Data Collection 
Crystal Se1 Se1 Se1 Native 
Wavelength λ1 (0.979104 Å) λ2 (0.97872 Å) λ3 (1.1627 Å) 0.9791 Å 
Source NSLS x25 NSLS x25 NSLS x25 NSLS x29 
Resolution 20–1.95 20–1.95 20–1.95 20-2.04 
Rsym (%) 5.1 (37.2) 5.0 (30.6) 4.8 (41.1) 5.7 (38.1) 
<I/σ> 29.9 (3.3) 31.1 (4.1) 33.0 (2.9) 35.8 (3.6) 
Completeness(%) 99.7 (100.0) 99.0 (100.0) 99.5 (100.0) 99.8 (99.7) 
Redundancy 6 6 6 7 
Phasing Power (Bijvoet Differences)a 
Wavelength Se 1 λ1 
1.29 (0.31) 
Se 1 λ2 
2.44 (0.67) 
Se 1 λ3 
0.302 (0.74) Acentric PP 
Phasing Power and FOM (Dispersive Differences)a 
Wavelength λ1 vs. λ3 
1.25   (0.547) 
0.919 (0.346) 
λ2 vs. λ3 
1.22 (0.730) 
0.886 (0.458) 
Acentric PP 
Centric PP 
Figure of Merit (FOM) 
Acentric FOM 0.585 (0.229) 
Centric FOM 0.457 (0.143) 
Refinement 
   RMS deviations 
Crystal Resolution R Factor R free Bond Length Bond Angle 
 (Å) (%) (%) (Å) (o) 
Se1a 20.0-1.90 20.7 24.6 0.007 1.037 
Nativeb 20.0-2.04 20.1 24.7 0.007 1.036 
B-factors 
Crystal Chain A Chain B 
 main chain overall main chain overall 
Se1a 26.47 27.18 36.66 37.10 
Nativeb 33.79 34.32 48.00 47.65 
a Grp163-399 K68A/H260Y 
b Grp163-399 K68A 
c Values in parentheses represent the highest resolution shell. 
d Rsym = ∑h∑j|Ij(h) - <I(h)>/ ∑h∑jIj(h). 
e R value for a 5% subset of reflections selected at random and omitted from refinement. 
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The individual domains in the Grp1 Sec7-PH tandem are structurally similar to the 
isolated ARNO Sec7 domain (29, 150) and Grp1 PH domain (147, 151, 152).  The Sec7 
domain consists of an N-terminal subdomain with 7 helices (αA-αG) and a C-terminal 
three helix bundle (αH-αJ).  The PH domain consists of a 9 stranded partly open β-barrel 
(β1- β7 and βi1- βi2) capped by a C-terminal helix (α1).  Ins(1,3,4,5)P4 is bound at the 
open end of the b-barrel as described (151, 152).  Residues 251-265 in the linker between 
the Sec7 and PH domains adopt an ordered though non-uniform secondary structure.  
Following the PH domain, residues 383-395 form an amphipathic helix, hereafter 
referred to as the C-terminal helix.  The C-terminus of this helix is encoded by the first 5 
residues of the polybasic motif (391RKRRI395).  No electron density was observed for 
the last 2 residues of chain A and last 5 of chain B. 
 Both molecules in the asymmetric unit exhibit a similar organization in which the 
Sec7 domain interacts extensively with the linker and C-terminal helix but does not 
directly contact the PH domain (Figure 2.3).  Although the relative orientation of the 
Sec7 and PH domains differs, the linker and C-terminal helix adopt similar structures and 
mediate equivalent interactions with the Sec7 domain (Figure 2.6).  The electron density 
is weaker for chain B, reflecting higher overall B-factors (Figure 2.7 and Table 2.3).  The 
B-factors are also higher for the linker and C-terminal helix in both molecules, consistent 
with the role of these regions as surface regulatory elements. 
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Figure 2.6  Comparison of the two molecules in the asymmetric unit following 
superposition of the Sec7 domains. 
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Figure 2.7 B-factors for main chain atoms of molecule A and B in the   
  asymmetric unit for native crystals of Grp163-399. 
The view and orientation is similar to Figure 2.3.  B-factors from the main chain atoms of 
the refined structure are mapped to the ribbon representation with color gradient 
proportional to the B-factor.  The overall B-factor is higher in chain B than in chain A.   
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As shown in Figure 2.8, the non-polar linker residues Phe 262 and Leu 258 occupy a 
hydrophobic pocket bounded by Ile 165 in αG and Phe 195, Ile 198 and Met 199 in αH 
while a pair of acidic residues (Asp 254 and Asp 257) engage Arg 157 in the αF-αG 
loop.  Likewise, Pro 383, Phe 384, Met 387, Leu 388 and Lys 392 from the non-polar 
face of the C-terminal helix pack with non-polar residues in αG (Ala 162 and Ile 165) 
and αH (Tyr 191, Val 192, and Phe 195).  In addition, Arg 391 and Arg 394 from the 
polybasic motif contact acidic residues in αG (Glu 170) and αH (Asp 188). 
 
Pseudo-substrate mechanism of autoinhibition 
 In the crystal structures of Sec7 domains in complex with Arf1 (88, 91, 92), the 
Arf GTPase binding epitope is centered on the αG and αH helices and the αF-αG loop.  
The switch I region docks in a hydrophobic groove formed by the termini of αF, αG and 
aH whereas the switch II region engages residues in αG and αH.  A critical glutamate in 
the αF-αG loop, termed the glutamic acid finger, promotes GDP release through 
electrostatic repulsion with the β phosphate (88, 110) and contacts the invariant P-loop 
lysine in the nucleotide free complex (92).  As shown in Figure 2.8, the linker and C-
terminal helix in the autoinhibited Grp1 structure occlude the docking sites for the switch 
I and II regions, respectively.  Moreover, the mode of interaction strongly resembles that 
of the switch regions, despite differences in detail.  Thus, Cytohesin family GEFs are 
autoinhibited by a pseudo-substrate mechanism in which elements proximal to the PH 
domain occlude the Arf binding site.  In contrast to the Arf1-Sec7 domain complexes,  
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Figure 2.8 Pseudosubstrate autoinhibition by the Sec7-PH linker and C-terminal  
  helix. 
(A) Intramolecular interactions at the interface between the linker and Sec7 domain. (B) 
Intramolecular interactions at the interface between the C-terminal helix and Sec7 
domain.  (C and D) Comparison of the linker and C-terminal helix of Grp1 with the 
switch I and II regions of Arf1-GDP from the complex with the E156K mutant of the 
ARNO Sec7 domain (PDB ID code 1R8S) following superposition of Cα atoms. 
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however, the autoinhibitory elements do not alter the disposition of the N- and C-terminal 
subdomains of the Grp1 Sec7 domain compared with the ARNO Sec7 domain alone. 
 
Structure-based mutational analysis of the determinants of autoinhibition 
 To identify determinants of autoinhibition, we analyzed the effects of amino acid 
substitutions on the catalytic efficiency.  All mutants expressed in a soluble form at wild 
type levels.  As shown in Figure 2.9, substitutions in the C-terminal helix of Grp1 result 
in partial activation, with the largest increases in kcat/KM observed for L388A and K392A 
(20 and 27 fold, respectively).  Both residues are located on the non-polar face of the C-
terminal helix.  Leu 388 is entirely buried in the hydrophobic groove between aG and aH.  
Although the amino group of Lys 392 is exposed and does not participate in 
intramolecular interactions, the non-polar portion of the side chain buries otherwise 
exposed hydrophobic residues on aH.  The double substitution L388A/K392A is as 
strongly activating as deletion of the polybasic motif.  Furthermore, the helix 
destabilizing substitution A389G also exhibits a large (10 fold) effect.  Significant though 
weaker activation (3-6 fold) is observed for substitutions (M387A, R391A, R393A and 
R394A) involving other residues that mediate polar and/or non-polar interactions in or 
proximal to the switch II binding site.  Although less extensively analyzed, similar results 
were obtained for substitutions in Cytohesin-1 and ARNO, consistent with a conserved 
autoinhibitory mechanism. 
 Substitutions involving linker residues that are buried in the interface with the 
switch I docking site are prone to aggregation.  Low solubility prevented further  
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Figure 2.9 Structure-based mutational analysis of the determinants of   
  autoinhibition 
Catalytic efficiencies are plotted on a log scale in units of the catalytic efficiency for the 
corresponding wild type Sec7-PH-polybasic construct.  Mean values and standard 
deviations were calculated for two independent measurements. 
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characterization of the L258A and L258E mutants.  However, the F262A and F262E 
mutants are both soluble in 1M NaCl.  Under these conditions, the catalytic efficiency of 
the construct lacking the polybasic motif is diminished by less than 40% while the 
catalytic activity of the corresponding construct with an intact polybasic motif increases 3 
fold.  The F262A and F262E substitutions further increase kcat/KM by 2 fold and 7 fold, 
respectively, suggesting that the linker contributes to the stability of the autoinhibited 
conformation, in addition to blocking the switch I docking site. 
 
Determinants of autoinhibition are important for plasma membrane targeting 
 The polybasic motif enhances partitioning of ARNO and Cytohesin-1 with 
liposomes containing PtdIns(4,5)P2 and/or phosphatidyl serine (PtdSer) (137, 149) and is 
required for the plasma membrane targeting of Cytohesin-1 in Jurkat cells (137).  To gain 
further insight into the relationship between autoregulation of exchange activity and 
plasma membrane targeting, we examined the effects of truncation and site specific 
mutants on the insulin stimulated recruitment of 2G Grp1 and 3G Cytohesin-1 constructs 
in 3T3 L1 adipocytes.  The rounded morphology of 3T3 L1 adipocytes and limited extent 
of membrane ruffling following insulin stimulation simplifies the analysis of plasma 
membrane targeting (160). 
 As shown in Figure 2.10, full length 2G Grp1 exhibits robust insulin stimulated 
accumulation at the plasma membrane compared with the predominately cytoplasmic 
distribution in serum starved cells.  A construct spanning the PH domain and polybasic 
motif also targets the plasma membrane in >80% of cells; however, the degree of  
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Figure 2.10 Determinants of plasma membrane targeting in 3T3 L1 adipocytes 
(A) Representative examples of the localization of GFP-fusion constructs in serum 
starved (-) and insulin stimulated (+) cells.  (B) Percentage of cells for which plasma 
membrane targeting was observed.  Mean values and standard deviations are plotted for 2 
independent experiments.  Approximately 100 cells were analyzed for each experiment. 
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accumulation does not appear to be as strong as for the full length protein, suggesting that 
elements N-terminal to the PH domain contribute weakly to plasma membrane targeting, 
possibly through homo/hetero-dimerization mediated by the heptad repeats or through 
interaction of the Sec7 domain with Arf6.  Deletion of the polybasic motif diminishes but 
does not eliminate plasma membrane targeting. 
 For 3G Cytohesin-1, accumulation at the plasma membrane is evident in 50-60% 
of cells expressing either the full length protein or a construct spanning the PH domain 
and polybasic motif.  Consistent with earlier studies in Jurkat cells (137), little insulin 
stimulated plasma membrane localization is observed for a construct lacking only the 
polybasic motif, even though PtdIns(3,4,5)P3 production is required as evidenced by the 
dependence on insulin stimulation and sensitivity to the PI 3-kinase inhibitor 
wortmannin.  The requirement of the polybasic motif for 3G Cytohesin-1 but not 2G 
Grp1 is consistent with the ~20 fold higher affinity of the 2G variants for PtdIns(3,4,5)P3 
(147).  Given that the plasma membrane localization of 2G Grp1 is only weakly sensitive 
to deletion of the polybasic motif, the effects of individual amino acid substitutions were 
examined in the context of full length 3G Cytohesin-1.  Remarkably, both the L385A and 
K389A mutants remain cytoplasmic upon insulin stimulation, indicating that critical 
determinants of autoinhibition also contribute to insulin stimulated plasma membrane 
recruitment.  Finally, the basal localization of Grp1 and Cytohesin-1 constructs observed 
in 5-30% of serum starved cells probably reflects a combination of factors including 
binding to PtdIns(4,5)P2, non-specific interactions between the electropositive surface of 
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the PH domain and the negatively charged inner leaflet of the plasma membrane, and 
residual levels of PtdIns(3,4,5)P3 following serum starvation. 
 
Mechanisms for reversal of autoinhibition 
 The active form of Arf6, but not Arf1, has recently been shown to co-precipitate 
Grp1 as well as ARNO and to enhance PtdIns(3,4,5)P3-dependent plasma membrane 
recruitment of both proteins (161).  Active Arf6 binds directly to the PH domain-
polybasic region of Grp1, but only in the presence of Ins(1,3,4,5)P4 (161).  To explore the 
hypothesis that autoinhibition can be partially or fully reversed by Ins(1,3,4,5)P4 
dependent Arf6 binding, the Arf1 exchange activity of two Grp1 constructs (Grp163-399 
and Grp163-390) was characterized as a function of the concentration of GppNHp-loaded 
Arf6 in the presence and absence of Ins(1,3,4,5)P4.  As shown in Figure 2.11A, Arf6-
GppNHp strongly stimulates the exchange activity of the autoinhibited Grp163-399 
construct.  Stimulation requires Ins(1,3,4,5)P4 and exhibits a hyperbolic dependence on 
the concentration of Arf6-GppNHp.  The observed rate constant is well described by a 
1:1 binding isotherm, yielding an maximum activation of 8 fold at saturation and a half 
maximal activation constant of 14 mM.  A more rigorous kinetic analysis at a saturating 
Arf6-GppNHp concentration of 80 mM indicates a 10 fold increase in kcat/KM (Figure 
2.11B).  Ins(1,3,4,5)P4 alone or in combination with GppNHp-loaded Arf1 has no effect  
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Figure 2.11 Mechanisms for partial activation of Grp1 family GEFs 
(A) Dependence of the observed rate constant for ΔN17Arf1 exchange catalyzed by 
Grp163-399 on the concentration of GppNHp-loaded or GDP-loaded Arf GTPases.  Solid 
lines represent fitted model functions for a 1:1 binding binding/activation isotherm.  (B) 
Dependence of the observed rate constant for ΔN17Arf1 exchange on the concentration 
of Grp163-399 in the presence and absence of 80 μM Arf6-GppNHp.  (C) Catalytic 
efficiencies for Cyothesin-1 phosphoproteins compared with the R378C reference protein.  
(D) Dependence of the observed rate constant for ΔN17Arf1 exchange catalyzed by wild 
type (WT) Cytohesin-153-398 or the 394DD395 double mutant on the concentration of 
GppNHp-loaded or GDP-loaded Arf GTPases.  Mean values and standard deviations 
were calculated for two independent measurements. 
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(Figure 2.11A).  Likewise, the combination of GDP-loaded Arf6 and Ins(1,3,4,5)P4 only 
weakly stimulates exchange activity.  In contrast, Arf6-GppNHp in combination with 
Ins(1,3,4,5)P4 does not stimulate that exchange activity of the nearly fully active  
Grp163-390 construct lacking the polybasic motif. 
 Cytohesin-1 and ARNO are specifically phosphorylated by PKC at sites (Ser 392 
in ARNO; Ser 394 and Thr 395 in Cytohesin-1) within the polybasic region in response 
to phorbol ester stimulation (148, 162).  Pseudophosphorylation mutants (S392E in 
ARNO; S394D/E or T395D/E in Cytohesin-1; and T390E in Grp1) result in 2-9 fold 
increases in kcat/KM (Figure 2.9).  The corresponding alanine substitutions also increase 
kcat/KM.  To assess the effect of phosphorylation, intein mediated ligation was used to 
prepare Cytohesin-1 constructs that are fully and specifically phosphorylated on Ser 394 
and/or Thr 395.  As a consequence of the ligation reaction, the resulting phosphoproteins 
contain a substitution (R378C) in the loop connecting the PH domain to the C-terminal 
helix.  The R378C substitution generated by site directed mutagenesis has a negligible 
(<2 fold) effect on the exchange activity and was used as a reference for the ligated 
phosphoproteins, which were separated from unligated reactants by purification over a 
phosphoprotein binding column followed by gel filtration on Superdex-75 (Figure 2.12).  
As shown in Figure 2.11C, the catalytic efficiencies of the ligated phosphoproteins are 5-
9 fold higher than that of the reference protein.  Dephosphorylation with alkaline 
phosphatase eliminates the increased catalytic efficiency of the ligated phosphoproteins 
but has no effect on the reference protein.  Thus, phosphorylation of either Ser 394 or  
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Figure 2.12 Purification of phosphorylated Cytohesin-1 R378C following intein 
  mediated ligation. 
(A) SDS-PAGE gel of fractions from a phosphopurification column (Qiagen). (B) Elution 
profile from Superdex-75 column.  Shown above the elution profile are fractions 
analyzed by SDS-PAGE. 
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Thr 395 in the polybasic region of Cytohesin-1 results in a large increase in exchange 
activity.  Conversely, partitioning with liposomes containing 20% PtdSer and 3% 
PtdIns(3,4,5)P3 with or without 10% PtdIns(4,5)P2 has no detectable effect on the 
catalytic efficiency of either Grp1 or Cytohesin-1 (Figures 2.13-2.14).  Finally, we note 
that Arf6-GppNHp in combination with Ins(1,3,4,5)P4 stimulates the exchange activity of 
Cytohesin-153-398 as well as the double pseudophosphorylation mutant (Figure 2.11D).  In 
this case, the half maximal activation constant appears to be greater than 100 mM (data 
not shown), possibly reflecting the lower affinity of the 3G splice variants for 
Ins(1,3,4,5)P4. 
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Figure 2.13 Effect of liposomes on the ΔN12Arf6 exchange activity of  
  Grp163-399. 
(A and B) The catalytic activity of autoinhibited Grp163-399 (2 mM) was measured as a 
function of liposome concentration.  (C and D) Co-sedimentation of Grp163-399 with 
liposomes under the same conditions as in panels A and B.   SDS-PAGE gels were 
quantified using GelEval 1.1.  Plots below the gels represent the mean and standard 
deviation of the background corrected integrated band intensity for 2 independent 
determinations. 
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Figure 2.14 Effect of liposomes on the ΔN12Arf6 exchange activity of  
  Cytohesin-153-398. 
(A and B) Catalytic activity of autoinhibited Cytohesin-153-398 (2 mM) as a function of 
liposome concentration.  (C and D) Co-sedimentation of Cytohesin-153-398 with liposomes 
under the same conditions as in panels A and B.   SDS-PAGE gels were quantified using 
GelEval 1.1.  Plots below the gels represent the mean and standard deviation of the 
background corrected integrated band intensity for 2 independent determinations. 
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Discussion 
 Autoinhibition has been observed in GEFs for several GTPase families and may 
represent a widespread regulatory mechanism.  The underlying structural bases have been 
characterized for the Rho family GEF Vav (60) and the Ras/Rho family GEF Sos (59, 
71).  Vav and Sos both contain a DH-PH tandem that activates Rho family GTPases 
(163-165).  Sos also contains a CDC25 domain that activates Ras (166).  The DH domain 
of Vav is directly autoinhibited by an N-terminal extension, which physically blocks the 
GTPase binding site through a largely non-polar interface centered on a buried tyrosine 
residue provided by the N-terminal extension (60).  Tyrosine phosphorylation releases the 
N-terminal extension, exposing the catalytic site.  The Ras exchange activity of Sos is 
regulated by the GTP-bound form of Ras, which stabilizes a high activity conformation 
of Sos by binding to an allosteric site on a surface distal to the catalytic site (71).  The 
Ras exchange activity is further autoinhibited by the DH-PH tandem, which competes 
with the binding of Ras-GTP to the allosteric site (59). 
 Here we have shown that Grp1 family GEFs are autoinhibited through a pseudo-
substrate interaction whereby the linker and C-terminal helix block the binding sites for 
the switch I and II regions of Arf GTPases.  The simplest activation mechanism would 
require two states, a 'closed' state corresponding to the autoinhibited conformation and an 
'open' state in which the Arf binding site is accessible.  The latter could correspond to an 
alternative ordered conformation or one in which the linker and C-terminal regions are 
dynamic.  Like Vav, the autoinhibited state is catalytically incompetent.  Consequently, 
the residual exchange activity of full length Grp1 family GEFs can be interpreted as 
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evidence that a small fraction of the total population exists in the open conformation at 
equilibrium.  Assuming the open conformation has a catalytic activity equivalent to the 
isolated Sec7 domain, the fractional concentration can be estimated as 1-2%, implying an 
equilibrium constant of 1-2 x 10-2.  In the context of this two state mechanism, the 
binding of active Arf6 might in principle shift the equilibrium to the open conformation 
by binding simultaneously to the PH domain as well as the C-terminal helix and/or linker 
region.  Such a binding modality involving a PH domain and a C-terminal helix has 
recently been observed in the crystal structure of active Arf1 in complex with the Arf 
binding region of ARHGAP21 (167).  Alternatively, the binding of active Arf6 to the PH 
domain may selectively destabilize the closed conformation through steric overlap with 
the Sec7 domain.  Phosphorylation of PKC sites in the polybasic motif of Cytohesin-1 
might in principle shift the equilibrium towards the open conformation through an 
intramolecular rearrangement stabilized by attractive electrostatic interactions between 
the doubly negatively charged phosphate groups and positively charged residues in the 
polybasic motif or through destabilization of the C-terminal helix resulting from 
repulsive interactions between the phosphate groups and the negative end of the 
macroscopic helix dipole.  A more detailed understanding of the structural basis for 
activation awaits future studies.  
 Grp1 family GEFs exhibit a clear preference for Arf1 in vitro (76, 135), with a 5-
20 fold higher kcat/KM compared with Arf6 (Table 2.1-2.2).  In transfected cells, Grp1 
family GEFs activate Arf6 (134, 135) as well as Arf1 (161).  Although autoinhibition has 
little effect on substrate specificity in vitro, it may contribute indirectly to the specificity 
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in vivo by reducing the basal level of Arf GTPase activation such that efficient exchange 
would require co-localization and/or relief of autoinhibition.  Provided that the effect of 
autoinhibition is primarily on KM rather than kcat, as expected for a simple 
pseudosubstrate mechanism involving occlusion of the active site, the high effective 
concentrations achieved by PtdIns(3,4,5)P3-dependent plasma membrane co-localization 
of Arf6 with Cytohesin family GEFs would be expected to selectively enhance activation 
of Arf6. 
 Polybasic regions have been implicated in the targeting and activation of 
signaling and trafficking complexes.  In MARCKS, for example, a polybasic region 
consisting of alternating basic and hydrophobic residues exhibits multivalent binding to 
anionic membranes with a cooperative dependence on the mole fraction of PtdIns(4,5)P2 
(168).  Although unfolded in solution, the MARCKS polybasic region interacts with 
membranes in an extended conformation, allowing the hydrophobic side chains to 
partition into the non-polar region of the bilayer while the basic side chains sequester 
multiple molecules of PtdIns(4,5)P2 through long range electrostatic interactions (169, 
170).  Polybasic motifs further contribute to the plasma membrane targeting of many 
small GTPases through a mechanism that requires PtdIns(3,4,5)P3 as well as 
PtdIns(4,5)P2 (171).  In another well characterized example, the actin regulatory protein 
N-WASP is autoinhibited though intramolecular interactions involving a binding site for 
the Cdc42 GTPase (172) and an adjacent polybasic region (173).  Autoinhibition can be 
relieved in a combinatorial manner by Cdc42 binding (172) and/or though cooperative, 
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multivalent binding of the polybasic region to membranes containing PtdIns(4,5)P2 (174).  
Given the distal location of the C-terminal helix relative to the head group binding site in 
the PH domain, simultaneous head group binding and non-specific membrane 
partitioning seems unlikely unless the C-terminal helix adopts an extended structure in 
the open conformation, in which case the terminal residues of the polybasic motif might 
be appropriately disposed for non-specific membrane interactions.  Even in the absence 
of direct contact with membranes, the high net positive charge (+6 to +8) of the polybasic 
motif would be expected to enhance the positive electrostatic potential of the PH domain 
and thereby contribute indirectly to the non-specific component of membrane 
partitioning.  Phosphorylation of PKC sites in Cytohesin-1 may reduce the non-specific 
contribution to membrane partitioning as observed for ARNO (148); however, the 
pseudo-phosphorylation mutants evidently do not alter the PtdIns(3,4,5)P3-dependent 
localization of Cytohesin-1 (162). 
 Under the conditions of our experiments, membrane partitioning does not appear 
to directly influence the stability of the autoinhibited conformation.  It remains possible 
that a specific lipid component and/or membrane composition would be capable of 
shifting the equilibrium towards the open conformation.  Our experiments also do not 
exclude the possibility of a more elaborate activation mechanism that would require the 
full length myristoylated form of Arf substrates.  Nevertheless, the observation that 
insulin stimulated membrane targeting of Cytohesin-1 is abrogated by site specific 
substitutions in the C-terminal helix that also relieve autoinhibition strongly suggests that 
activation is mechanistically coupled to membrane targeting.  An intriguing possibility is 
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that the binding site for active Arf6, which contributes to both plasma membrane 
targeting (161) and relief of autoinhibition, would include the C-terminal helix. 
 Taking into account the observations discussed above, we propose the model 
shown in Figure 2.15, in which the initial plasma membrane recruitment of Cytohesin 
family GEFs in response to PtdIns(3,4,5)P3 production is followed by lateral association 
with GTP-bound Arf6.  In addition to enhancing PtdIns(3,4,5)P3-dependent membrane 
recruitment (161), lateral association with GTP-bound Arf6 would simultaneously shift 
the equilibrium towards the active conformation.  Other plasma membrane proximal 
events, including phosphorylation of PKC sites in the polybasic motif of Cyothesin-1, 
may further shift the equilibrium to achieve full activation or otherwise represent an 
independent pathway for activation.  Finally, it is interesting to note that the 
constitutively active form of the Arf-like GTPase Arl4, which depends on a C-terminal 
polybasic motif for localization to the plasma membrane, has recently been shown to bind 
to the PH-polybasic region of ARNO and facilitate plasma membrane recruitment of 
ARNO as well as the other members of the Cytohesin family (175).  Additional 
experiments will be necessary to test the proposed model for autoregulation, investigate 
other potential mechanisms for activation, and determine whether the different activation 
mechanisms function synergistically or represent independent activation pathways. 
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Figure 2.15 Model for autoregulation of Cytohesin family GEFs 
Following PtdIns(3,4,5)P3-dependent plasma membrane recruitment of Grp1 family 
GEFs, lateral association with Arf6-GTP simultaneously enhances membrane partition 
and shifts the equilibrium towards the catalytically competent conformation.  Other 
mechanisms, including phosphorylation of PKC sites in the polybasic motif of  
Cytohesin-1, may be required for full activation. 
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Experimental Procedures 
Constructs, Expression and Purification 
 Constructs were amplified using Vent polymerase (NEB), digested with SalI and 
BamHI or BglII, and ligated into a modified pET15b vector incorporating an N-terminal 
6xHis tag (MGHHHHHHGS).  Mutants were generated using the Quick-Change II XL 
kit (Stratagene).  Wild type and mutant constructs were sequenced and expressed in 
BL21(DE3)RIL cells (Stratagene) cultured in 2X YT-amp (16 g tryptone, 10 g yeast 
extract, 5 g NaCl and 100 mg ampicillin per L).  Cultures were grown at 20°C to an 
OD600 of 0.4 and induced with 0.05 mM IPTG for 16 hrs.  Cells were disrupted by 
sonication in 50 mM Tris pH 8.0, 0.1% 2-mercaptoethanol, 0.1 mM PMSF, 1 mg/ml 
lysozyme, 2 mM MgCl2, 0.01 mg/ml DNase I.  Lysates were supplemented with 0.5% 
Triton X-100 and centrifuged at 35000 g for 45 minutes.  Supernatants were loaded onto 
NiNTA-agarose columns (Qiagen) equilibrated with 50 mM Tris, pH 8.0, 0.1% 2-
mercaptoethanol.  The columns were washed with buffer containing 15 mM imidazole 
and eluted with a gradient of 10-250 mM imidazole.  For crystallization, proteins were 
further purified by chromatography on Source Q and Superdex-200 (GE Health Care). 
 
Exchange Assays 
 Exchange kinetics were monitored using either the increase in intrinsic tryptophan 
emission intensity accompanying activation of Arf GTPases or the decrease in emission 
intensity accompanying release of mant-GDP.  Exchange reactions were initiated by 
mixing GDP-loaded or mant-GDP-loaded NΔ17Arf1 or NΔ12Arf6 at a final 
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concentration of 1 µM with varying concentrations of exchange factor in the presence of 
200 or 250 µM GppNHp.  Data were collected with a Saphire multimode microplate 
spectrophotometer (Tecan) or a PC1 spectrofluorimeter (ISS), using excitation and 
emission wavelengths of, respectively, 300 nm and 335 nm (tryptophan fluorescence) or 
360 nm and 440 nm (mant fluorescence).  Observed pseudo first order rate constants 
(kobs) were extracted from a non-linear least squares fit to 
I(t) = (I0 - I∞) exp(-kobs t) + I∞ 
where I(t) is the emission intensity as a function of time and I0 and I∞ are the initial and 
final emission intensities, respectively.  Catalytic efficiency (kcat/KM) was obtained from 
the slope of a linear least squares fit to 
kobs = (kcat/KM) [Sec7] + kintr 
where kintr is the intrinsic rate constant for GDP or mant-GDP release. 
 
Exchange Assays for Liposome Partitioning Experiments 
 The kinetics of nucleotide exchange were monitored using the decrease in 
fluorescence accompanying release of mant-GDP from Arf GTPases.  Exchange 
reactions were initiated by the addition of mant-GDP loaded N NΔ17Arf1 or NΔ 12Arf6 
(1 µM unless otherwise indicated) and varying concentrations of exchange factor in the 
presence of 250 µM GppNHp.  Data were collected using a Saphire multimode 
microplate spectrophotometer (Tecan).  Samples were excited at 360 nm and the 
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emission detected at 440 nm.  Observed pseudo first order rate constants (kobs) were 
extracted from a nonlinear least-squares fit to the exponential function 
I(t) = (I0 - I∞) exp(-kobs t) + I∞ 
where I(t) is the emission intensity as a function of time and I0 and I∞ are the initial and 
final emission intensities, respectively.  The catalytic efficiency, kcat/Km, was obtained 
from the slope of a linear least squares fit to 
kobs = (kcat/Km) [Sec7] + kintr 
where kintr is the intrinsic rate constant for mant-GDP release. 
 
Liposome Partitioning 
 Phospholipids (Avanti) and phosphoinositides (Cell Signals) were dissolved in 
chloroform, mixed in the desired molar ratios using a Drummond pipettor, dried by 
evaporation, and rehydrated in 50 mM Tris, pH 8.0, 150 mM KCl, 1 mM MgCl2.  Small 
unilamellar vesicles (SUVs) were prepared by rapid freeze-thaw cycling in liquid 
nitrogen (10 cycles) followed by bath sonication for 30 minutes.  Proteins were added to 
a final concentration of 2 mM and the resulting mixtures incubated for 1 hour at 25°C 
followed by centrifugation at 100,000 g for 1 hr at 25°C.  Pellets were redissolved in an 
equivalent volume.  Samples were analyzed by SDS-PAGE with Coomassie Blue 
staining and quantified using the GelEval 1.1. 
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Nucleotide Loading 
 Arf GTPases were incubated with a 20 fold excess of nucleotide (GppNHp, GDP 
or mant-GDP) for 1-5 hours at 20°C in 50 mM Tris, pH 8.0, 150 mM NaCl, and 1mM 
EDTA.  MgCl2 was added to 10 mM and unbound nucleotide removed by gel filtration 
over a D-salt column (Pierce). 
 
Crystallization and Data Collection 
 Selenomethionine substituted Grp163-399 with two substitutions (K68A and 
H260Y) was mixed in a 1:1.2 molar ratio with Ins(1,3,4,5)P4 and crystallized at 4°C in 
hanging drops containing 10-15% PEG 6000, 50 mM Tris, pH 8.0, and 0.2 M Li2SO4.  
H260Y is a spurious mutation that has no effect on the catalytic efficiency.  Crystals were 
transferred to a cryoprotectant solution (15% PEG 6000, 25% PEG 400, 50 mM Tris, pH 
8.0, 0.2 M Li2SO4) and frozen in liquid propane.  The crystals are in the space group 
P212121 with a = 83.5 Å, b = 94.6 Å, c = 115.3 Å.  The unit cell volume is consistent with 
2 molecules in the asymmetric unit and a solvent content of 58%.  Using the NSLS X25 
beamline, complete data sets were collected on a single crystal at the f' maximum and f'' 
minimum of the selenium edge and at a high energy remote wavelength.  The crystal was 
maintained at 100°K in a nitrogen cryostream (Oxford cryosystems).  Crystals of the 
single K68A mutant in complex with Ins(1,3,4,5)P4 were subsequently obtained at 4°C in 
hanging drops containing 10% PEG 4000, 50 mM Tris, pH 8.2, and 50 mM LiSO4.  The 
crystals are in the space group P212121 with cell constants a = 83.0 Å, b = 94.7 Å, c = 
115.3 Å.  Crystals were soaked in a cryoprotectant solution (15% PEG 4000, 25% PEG 
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400, 0.05 M Li2SO4, 50 mM Tris, pH 8.2) and frozen in liquid nitrogen.  A data set 
complete to 2.0 Å was collected at the NSLS X29 beamline.  Data were processed with 
Denzo and scaled with Scalepack (176). 
 
Structure Determination and Refinement 
 The structure of K68A/H260Y Grp163-399 in complex with Ins(1,3,4,5)P4 was 
solved by multiwavelength anomalous diffraction (Table 2.3 and Figure 2.5).  Selenium 
sites were identified from a 3.0 Å molecular replacement solution and refined using 
SHARP (177).  Following phase-improvement by solvent flipping, a σA-weighted 
Fourier summation yielded an interpretable map.  An initial model was constructed with 
ARP/wARP and completed by manual model building in O (178, 179).  The model was 
refined by simulated annealing in CNS (180), atom updating in ARP/wARP (181), and 
manual rebuilding in O.  The final refined model includes residues 63-397 (molecule A), 
residues 63-394 (molecule B), 976 water molecules, 7 sulfate ions, and 2 molecules of 
PEG.  The structure of the K68A mutant of Grp163-399 was solved by molecular 
replacement using Phaser (182) and refined as described for the double mutant (Table 2.3 
and Figure 2.6).  The final refined model includes residues 63-397 (chain A), residues 63-
394 (chain B), 584 water molecules, 7 sulfate ions, and 3 molecules of PEG. 
 
Adipocyte Localization Experiments 
 Constructs were cloned into the expression vector pEGFP-c1 (Amersham) for 
expression with enhanced green fluorescent protein (eGFP) fused to the N-terminus.  3T3 
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L1 fibroblasts were cultured in DMEM supplemented with 10% FBS, 50 units/ml 
penicillin, 50 mg/ml streptomycin and differentiated to adipocytes as described (183).  
Day 6-8 3T3 L1 adipocytes were electroporated with 40 µg of plasmid DNA, seeded on 
sterile glass cover slips, cultured for 12 hrs and serum starved for 4 hrs in the absence of 
FBS.  Serum starved cells were stimulated with 100 nM human insulin (Eli Lilly), or 
treated with an equivalent volume of serum free medium, and incubated for 30 min at 
37°C.  For experiments involving inhibition of PI 3-kinase, wortmannin was added to a 
final concentration of 100 nM followed by incubation at 37°C for 15 min prior to 
stimulation with insulin.  Cover slips containing adherent cell cultures were washed 3 
times with PBS, incubated at room temperature for a minimum of 20 min in 4% 
paraformaldehyde/PBS.  Following fixation, cover slips were washed with PBS and 
mounted on glass slides with ProLong Gold antifade reagent (Invitrogen).  Cells were 
visualized with a Zeiss Axiovert 200 microscope using 63x or 100x oil immersion 
objectives and filters for FITC.  Digital images were acquired with a cooled CCD camera 
using the Axiovision software supplied by the manufacturer.  A minimum of 2 images 
were acquired for each cell at different z-planes.  The percentage of cells exhibiting 
plasma membrane localization was determined using at least 100 cells.  Error bars were 
calculated for 2 independent experiments. 
 
Formation of Arf6-GppNHp complexes with Cytohesin family GEFs 
 Grp1, Cytohesin-1 and ARNO at a concentration of 100 nM were incubated with 
or without varying concentrations of Ins(1,4,5)P3 or Ins(1,3,4,5)P4 for 30 minutes at 20°C 
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in 50 mM Tris, pH 8.0, 150 mM NaCl and 2 mM MgCl2.  Varying concentrations of 
Arf6-GppNHp were added and the incubation continued for an additional 3 hours. 
 
Generation of phosphorylated Cytohesin-1 
             A Cytohesin-1 construct (residues 53-377) was sub-cloned pTXB1 (NEB) 
upstream of the GyrA intein and chitin-binding domain (CBD).  Following expression in 
BL21(DE3)RILP cells at 20°C for 16 hrs, cells were lysed by sonication.  The lysate was 
loaded onto a chitin column equilibrated with 20 mM Tris, pH 8.0, 150 mM NaCl.  After 
extensive washing with 20 mM Tris, pH 8.0, 1.0 M NaCl, 1 mM EDTA, 0.1% Triton X-
100, the column was incubated with 50 mM Tris, pH 8.8, 150 mM NaCl, 10% glycerol, 
100 mM PMSF, 100 mM MESNA for 48 hours at 25°C.  The resulting Cyt53-377-MESNA 
derivative was concentrated and further purified on Superdex-75 in buffer containing 50 
mM MESNA.  Native chemical ligation was performed by incubation of a 5--10 fold 
excess of the mono- or di-phosphorylated synthetic peptide CDPFYEMLAARKKKVS-
(S/pS)-(T/pT)-KRH to 0.2 mM Cyt53-377 in a buffer containing 320 mM MESNA for 18 
hrs at 25°C.  The ligated product was isolated over a phosphoprotein purification column 
(Qiagen) followed by gel filtration chromatography on Superdex-75 equilibrated with 10 
mM Tris, pH 8.0, 150 mM NaCl, 50 mM MESNA. 
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CHAPTER III 
 
Kinetic mechanism for nucleotide exchange by the catalytic 
cores of Cytohesin-1 and Rabex-5 
 
Summary 
 Vesicular trafficking depends on activation of Rab and Arf GTPases by guanine 
nucleotide exchange factors (GEFs).  The catalytic core of Rab5 GEFs consists of a 
helical bundle (HB)-Vps9 domain tandem, which is structurally unrelated to the Sec7 
domain of Arf GEFs.  Nevertheless, Sec7 and Vps9 domains engage their respective 
GTPases in a similar manner and supply a crucial acidic residue to stabilize the 
nucleotide free complex.  Here, we report a stopped flow kinetic investigation of the 
intrinsic and GEF-catalyzed exchange reactions for Arf1 and Rab5 at physiological and 
low Mg2+ levels.  Slow intrinsic rates of nucleotide dissociation increase 50 fold when the 
Mg2+ concentration is reduced below 1 μM.  In contrast, the Cytohesin-1 Sec7 domain 
and Rabex-5 HB-Vps9 tandem can accelerate the rate of nucleotide dissociation by at 
least 105 fold.  Similar catalytic efficiencies (kcat/KM) as well as lower limits on the rate 
(kcat) and steady state (KM) constants were observed for the GDP dissociation reactions at 
physiological Mg2+ levels.  Although kcat/KM increases at low Mg2+ concentrations, the 
acceleration of GDP release decreases, suggesting that both GEF cores promote Mg2+ 
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release.  Moreover, the lower limits on kcat and KM are comparable to the highest values 
reported for other well characterized GEFs including the Sec2 GEF for the yeast Rab8 
ortholog Sec4.  The high kcat and KM values likely reflect dual requirements for tight 
control of catalytic output in the context of membrane targeting and autoregulatory 
mechanisms.  In this chapter, Meng-tse Lee carried out all of the experimental work.  
Anna Delprato helped to make one construct and carried out some pilot experiments.  
David Lambright derived the analytical solution for the dual steady state model.   
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Introduction 
 Arf and Rab GTPases are critical regulators of vesicular trafficking (1, 5, 184).  
Like other members of the Ras superfamily, they cycle between GDP bound (inactive) 
and GTP bound (active) conformations.  In the absence of other factors, the timescale for 
activation by nucleotide exchange and deactivation by GTP hydrolysis is slow compared 
to that of relevant cellular processes.  Consequently, progression through the GTPase 
cycle is typically controlled by guanine nucleotide exchange factors (GEFs) and GTPase 
activating proteins (GAPs), which can accelerate the rates of interconversion by several 
orders of magnitude. 
 Membrane targeting of Arf GTPases depends on partitioning of a myristoylated 
N-terminal amphipathic helix.  In the GDP bound state, the interswitch region adopts a 
retracted conformation, allowing formation of a hydrophobic pocket into which the 
myristoylated N-terminal helix is docked (17, 18).  During activation, the interswitch 
region undergoes a two residue register shift that displaces the myristoylated N-terminal 
helix, exposing it for partitioning with phospholipid bilayers (21, 92).  In the absence of 
membranes, full length Arf GTPases are poor substrates for GEFs whereas Arf proteins 
lacking the N-terminal helix are readily activated (185).  Rab GTPases, on the other hand, 
require C-terminal prenylation (typically geranyl geranylation) for Rab GDI-mediated 
transfer between membranes and do not undergo the interswitch toggle characteristic of 
Arf proteins (44).  Thus, full length and truncated Rab GTPases lacking the N- and/or C-
terminal hypervariable elements are typically activated by GEFs with similar efficiency 
in solution.  For both Arf and Rab GTPases, co-localization with GEFs increases the 
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effective concentration of both components and, consequently, the rate of activation.  
From a kinetic perspective, this 'restricted volume effect' results in a substantially lower 
apparent Michaelis constant (KM) and concomitant increase in apparent catalytic 
efficiency (kcat/KM) with no change in turnover number (kcat).  Thus, detailed 
characterization of the kinetics of GEF-catalyzed nucleotide exchange in solution 
provides an important baseline framework for comparison with kinetic measurements 
made with full length, lipid modified GTPase and GEFs in membrane environments. 
 Arf GEFs are distinguished by a catalytic Sec7 domain homologous to a central 
region of the yeast Sec7 protein, which is essential for intra-Golgi transport (129).  The 
Cytohesins (Cytohesin-1, ARNO/Cytohesin-2, Grp1/Cytohesin-3, and Cytohesin-4) 
represent a metazoan subfamily of Brefeldin A-insensitive Arf GEFs with a domain 
architecture consisting of heptad repeats, a Sec7 domain, a pleckstrin homology (PH) 
domain, and a polybasic motif (112, 132, 133).  A wide range of cellular processes from 
cytoskeletal dynamics, endocytic trafficking, ErbB receptor signaling, insulin signaling 
and T-cell activation are associated with the Cytohesin family (79, 186).  Rab5 GEFs 
share a Vps9 domain defined by homology with the yeast Vps9 protein implicated in 
vacuolar protein sorting (187).  The mammalian Vps9 domain GEF Rabex-5 was 
identified by co-purification of an endogenous complex with the Rab5 effector Rabaptin-
5 (62).  The Rabex-5/Rabaptin-5 complex has higher Rab5 GEF activity than Rabex-5 
alone and cooperates with other factors to promote endosome fusion (61, 62, 103, 104).  
Rabex-5 has a modular architecture with an A20 Zn2+ finger, an inverted UIM motif, a 
helical bundle–Vps9 domain tandem (HB-Vps9 tandem), and a predicted amphipathic 
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helix.  The HB-Vps9 tandem has GEF activity for the Rab5 phylogenetic subgroup 
(Rab5, Rab21 and Rab22) but not other Rab GTPases (102).  The exchange activity of 
the catalytic cores in Cytohesins and Rabex-5 is suppressed through intermolecular 
interactions with C-terminal autoinhibitory elements (57, 112).  In both cases, 
mechanisms for full or partial relief of autoinhibition have been identified as have 
determinants of substrate recognition. 
 Despite unrelated folds, the Vps9 and Sec7 domains engage their respective 
nucleotide free GTPases in a strikingly similar manner, with the switch regions docking 
in a hydrophobic groove at the intersection of three helices while a crucial acidic residue 
– the glutamate finger in the Sec7 domain or aspartate finger in the Vps9 domain – 
stabilizes a collapsed P-loop conformation through interaction with the invariant lysine 
(57, 92).  Structures of Sec7 domain complexes with Arf1-GDP and Brefeldin A suggest 
that the glutamate finger may reduce GDP affinity in part through electrostatic repulsion 
with the β phosphate (88).   In the structure of an Arabidopsis thaliana Vps9 domain in a 
Mg2+ free ternary complex with the cognate Rab5 ortholog and GDP, the aspartate finger 
participates in a hydrogen bonding interaction with the β phosphate (188).  In most 
structurally characterized GEF-GTPase complexes, including those involving Sec7 and 
Vps9 domains, the Mg2+ and phosphate binding sites are either directly or indirectly 
perturbed/disrupted while the switch I region is maintained in an open conformation 
consistent with nucleotide egress.  Although reduction of [Mg2+] increases the rate of 
GDP release, it remains unclear whether disruption of Mg2+ binding by Vps9 or Sec7 
 92 
domain GEFs contributes to the rate of nucleotide release or whether other structural 
changes, such as displacement of the conserved switch I phenylalanine that packs against 
the guanine ring, are rate limiting.  Indeed, acceleration of GDP release from Ypt1 by the 
TRAPP complex is independent of [Mg2+], even though TRAPP supplies an element that 
interacts with the P-loop of Ypt1 in the nucleotide complex and could potentially 
interfere with Mg2+ binding (189). 
 Despite extensive characterization by structural, biochemical and cell biological 
approaches, the kinetic mechanisms have not been investigated in detail for the catalytic 
cores of Sec7 or Vps9 domain GEFs.  Consequently, the extent to which the structural 
similarities as well as differences are reflected in the kinetic properties is not known.  In 
this study, we describe a detailed, stopped-flow kinetic analysis of the nucleotide 
exchange reactions catalyzed by the Sec7 domain of Cytohesin-1 and HB-Vps9 tandem 
of Rabex-5, using the N-terminally truncated form of Arf1 and full length Rab5 as 
substrates.  The Cytohesin-1 Sec7 domain and Rabex-5 HB-VPS9 tandem have similar 
catalytic efficiencies for cognate GTPase substrates, high KM values, and accelerate the 
rate of nucleotide release by at least 105 fold.  Both GEF cores also accelerate GDP 
release to a greater extent at physiological than at low Mg2+ levels, suggesting that 
disruption of Mg2+ binding contributes substantially to the catalytic efficiency of 
nucleotide release. 
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Results 
 The interaction of any labeled or unlabeled nucleotide (GXP) with a GTPase (G) 
in the absence of a GEF will be discussed in terms of the coupled equilibria in Figure 3.1.  
Interactions with both nucleotides and GEFs will be discussed in the context of the 
coupled equilibria in Figure 3.2, which corresponds to the generally applicable allosteric 
competition model used in previous studies of GEF-GTPase reaction mechanisms (45, 
46, 49, 51, 94, 189, 190).  The dependence on Mg2+ is implicitly incorporated into the 
rate and equilibrium constants for the steps involving nucleotide association and 
dissociation, which are consequently functions of more elementary rate constants in 
schemes that include intermediates for Mg2+ binding. 
 
Mg2+ dependence of intrinsic nucleotide dissociation from N∆17Arf1 and Rab5 
 Mg2+ is required for high affinity nucleotide binding to Ras-like GTPases 
including Arf and Rab proteins.  Thus, an understanding of the intrinsic rate of nucleotide 
exchange at physiological and low Mg2+ levels is a prerequisite for detailed 
characterization of the more complex interactions with GEFs.  Three established 
fluorescent approaches were used to measure the Mg2+ dependence of the intrinsic rate of 
GDP release by Arf1 and Rab5.  The first method takes advantage of mant-GDP, which 
has a fluorescent N-methylanthraniloyl label attached to the 2'-/3'-hydroxyl group (50).  
For Ras and Ypt1, the kinetics of GEF catalyzed exchange differ for the 2' and 3' mant  
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 G + GXP•Mg2+ 
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Figure 3.1 Kinetic scheme for the interaction of Mg2+ with any nucleotide (GXP) 
  and GTPase (G).  
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Figure 3.2 Kinetic scheme for the interaction of any GEF, GTPase (G) and 
  nucleotide (GXP).  
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isomers (51, 189).  To address this issue, the kinetics of nucleotide release were 
examined using both mant-GDP and 3'-mant-2'-deoxy GDP (mant-dGDP).  The second 
method uses fluorescence resonance energy transfer (FRET) from donor tryptophans in 
Arf1 or Rab5 to mant-GppNHp.  The third method monitors differences in intrinsic 
tryptophan fluorescence between GDP- and GppNHp-bound states.  Since nucleotide 
release is expected to be rate limiting under the relevant range of experimental conditions 
(i.e. k-1 << k1[GppNHp] or k1[GDP]), the observed rate constants (kobs) should be 
identical, apart from statistical error, for the FRET and intrinsic tryptophan fluorescence 
measurements but may differ for the mant-GDP and/or mant-dGDP measurements, 
depending on the extent of interaction between the mant moiety and the protein. 
 As indicated in Figure 3.1, k-1 and k-1' for different nucleotides can be obtained by 
monitoring the mixing of G•GXP with excess GppNHp or mant-GppNHp at a 
physiological, and typically saturating, [Mg2+] of 5 mM or at a [Mg2+] below the Kd for 
binding to the GTPase.  The low [Mg2+] condition was obtained by addition of EDTA to 
a final concentration of 10 mM.  Under these conditions, the free [Mg2+] concentration is 
ca. 0.4 μM as calculated by MAXCHELATOR (191).  With the exception of the intrinsic 
tryptophan fluorescence experiments involving EDTA, the time courses for the intrinsic 
exchange reactions shown in Figure 3.3, at both physiological and low [Mg2+], are well 
described by a single exponential function 
[G•GDP] = [G•GDP]o exp(-kobs t)                                               (1) 
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Figure 3.3 Mg2+ dependence of intrinsic nucleotide exchange for N∆17Arf1 and 
  Rab5 monitored by complementary methods.   
(A) Time courses for exchange of 1 μM N∆17Arf1•mant-GDP (upper panel) or 
Rab5•mant-GDP (lower panel) with 10 μM GppNHp monitored by direct mant 
excitation.  (B) Time courses for exchange of 1μM N∆17Arf1•mant-dGDP (3'-mant-2'-
deoxy GDP, upper panel) or Rab5•mant-dGDP (lower panel) with 10 μM GppNHp 
monitored by direct mant excitation.  (C) Time courses for exchange of 1 μM 
N∆17Arf1•GDP (upper panel) or Rab5•GDP (lower panel) with 10 μM mant-dGppNHp 
monitored by intrinsic tryptophan to mant FRET.  (D) Time courses for exchange of 1 
μM N∆17Arf1•GDP (upper panel) or Rab5•GDP (lower panel) with 10 μM GppNHp 
monitored by intrinsic tryptophan fluorescence.  Exchange reactions were monitored at 5 
mM or 0.4 μM Mg2+.  Black lines represent maximum likelihood fits with single (panels 
A, B and D) or double (panel C) exponential model functions. 
 
 
  
 98 
as expected for a rate-limiting, first order dissociation step in the limit where kobs ≈ k-1.  
Similar dissociation constants (k-1 = 1.3-1.5 × 10-4 s-1) were observed for release of GDP,  
mant-GDP, and mant-dGDP from N∆17Arf1 (Table 3.1).  At low [Mg2+], nucleotide 
release is accelerated 50 fold (k-1' = 6.3 × 10-3 s-1), with little difference in k-1/k-1' for 
mant-GDP or mant-dGDP release (Figure 3.3A, B).  The higher signal-to-noise ratio for 
mant-GDP compared with mant-dGDP is consistent with the more hydrophobic 
environment for the 2' vs. the 3' hydroxyl in the Arf1•GDP structure (PDB ID code 
1HUR).  For Rab5, the dissociation rate constant ranges from 5.5 × 10-5 s-1 for GDP 
release monitored by the FRET method to 5.0 × 10-6 s-1 for mant-dGDP release 
monitored by direct mant excitation and is accelerated 50-140 fold at low [Mg2+].  Slower 
release of mant-GDP and mant-dGDP compared to GDP likely reflects interaction of the 
mant label with Rab5, as suggested by the crystal structure of H-Ras bound to mant-
dGppNHp, in which the mant moiety is partially buried in a hydrophobic environment 
(72). 
 When monitored by intrinsic tryptophan fluorescence, two distinct kinetic phases 
are evident in the N∆17Arf1 and Rab5 exchange reactions initiated by addition of EDTA 
(Figure 3.3D).  The time courses are well described by a bi-exponential function 
I(t) = a1 exp(-kobs1 t) + a2 exp(-kobs2 t)                                            (2) 
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Table 3.1 Kinetic constants for intrinsic nucleotide dissociation at high and low [Mg2+] 
 N∆17Arf1 Rab5A 
Method k-1 
(× 10-4 s-1) 
k-1' 
(× 10-4 s-1) 
k-1 
(× 10-4 s-1) 
k-1' 
(× 10-4 s-1) 
mant-GDP 1.5 ± 0.2 69 ± 2 0.14 ± 0.02 10.8 ± 0.4 
mant-dGDP 1.4 ± 0.1 71 ± 3 0.05 ± 0.01 6.9 ± 0.2 
FRET 1.3 ± 0.1 63 ± 2 0.55 ± 0.02 31.4 ± 0.7 
Intrinsic Trp 1.4 ± 0.1 64 ± 1 0.58 ± 0.07 31.0 ± 0.4 
Mean ± standard deviation of the maximum likelihood values obtained by fitting 3 independent 
data sets with single or double exponential functions as described in the text.  k-1 and k-1' were 
determined with data collected at 5 mM Mg2+ or low Mg2+ (ca. 10-7 M in the presence of 10 mM 
EDTA), respectively. 
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The observed rate constant for the fast phase (kobs1) is four orders of magnitude greater 
than that for the slow phase (kobs2).  The value of kobs2 corresponds to the value of kobs 
obtained in the FRET experiment, indicating that the second phase reflects nucleotide 
exchange limited by GDP release.  Given that the fast phase was not observed in the 
absence of EDTA, it likely arises from rapid equilibration of Mg2+ bound and free states 
preceding GDP release such that 
kobs1 = kd + ka [Mg2+]                                                         (3) 
where kd and ka are the apparent rate constants for Mg2+ dissociation and association, 
respectively.  Since increasing the total [EDTA] by 5 fold — which lowers the free 
[Mg2+] by ca. 9 fold — had negligible affect on kobs1 (Table 3.2), it follows that kobs1 ≈ kd 
under the experimental conditions. 
 
Detection of Mg2+ and GDP dissociation by conserved tryptophan residues in Arf 
and Rab GTPases 
 To determine if the intrinsic tryptophan fluorescence is indeed sensitive to Mg2+ 
dissociation without concomitant GDP release, sequential mixing experiments were 
conducted in which the exchange reactions were aged for a time sufficient for 
equilibration of the fast phase but considerably shorter than the onset of nucleotide 
release (i.e. 1/kobs1 << τaged << 1/kobs2) prior to a second mixing step to increase the free 
[Mg2+] to 10 mM (Figure 3.4A).  For both N∆17Arf1 and Rab5, restoration of [Mg2+]  
 101 
Table 3.2 Summary of observed kinetic constants 
Experiment kobs1 kobs2 
 (s-1) (× 10-3 s-1) 
∆N17Arf1•GDP + 10 mM EDTA 83 ± 9  N.A. 
∆N17Arf1•GDP + 50 mM EDTA 90 ± 11 N.A. 
∆N17Arf1•mant-dGDP + 100 μM Sec7 21 ± 3 N.A. 
∆N17Arf1•mant-dGDP + 100 μM W150F Sec7 16 ± 1 N.A. 
∆N13Arf6•GDP + 10 μM  GppNHp N.A. 1.25 ± 0.03 
∆N13Arf6•GDP + (10 mM EDTA & 10 μM GppNHp)  N.A. 4.65 ± 0.03 
Rab5•GDP + 10 mM EDTA 12.5 ± 0.6 N.A. 
Rab5•GDP + 50 mM EDTA 12 ± 1 N.A. 
Rab5•GDP + (100 μM HB-Vps9 & 10 μM mant-dGppNHp)  0.75 ± 0.02 N.A. 
Rab5•GDP + (100 μM W247F HB-Vps9 & 10 μM mant-dGppNHp) 0.60 ± 0.02 N.A. 
Rab5•GDP + (10 mM EDTA & 10 μM GDP) 10.9 ± 0.9 3.10 ± 0.04  
Rab5•GDP + (10 mM EDTA & 10 μM mant-dGppNHp) N.A. 3.14 ± 0.07 
Rab6•GDP + (10 mM EDTA & 10 μM GDP) 5.1 ± 0.2 1.75 ± 0.08 
Rab6•GDP + (10 mM EDTA & 10 μM mant-dGppNHp) N.A. 1.5 ± 0.3 
Rab7•GDP + (10 mM EDTA & 10 μM GDP) 3.0 ± 0.1 10.9 ± 0.28 
Rab7•GDP + (10 mM EDTA & 10 μM mant-dGppNHp) N.A. 8.9 ± 0.9 
Mean ± standard deviation of the maximum likelihood values obtained by fitting single or 
biexponential model functions to 3 independent data sets as described in the text.  Time courses 
for Mg2+ removal and GDP/GppNHp exchange were monitored by intrinsic tryptophan 
fluorescence.  Time courses for GDP/mant-dGppNHp exchange were monitored by intrinsic 
tryptophan to mant-FRET.  Time courses for mant-dGDP release were monitored by direct mant 
excitation. 
 
N.A., Not applicable; Sec7, Cytohesin-1 Sec7 domain; HB-Vps9, Rabex-5 HB-Vps9 tandem. 
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Figure 3.4 Detection of Mg2+ removal and nucleotide state by intrinsic  
  fluorescence from conserved tryptophan residues in Arf and Rab  
  GTPases.   
(A) Time courses for Mg2+ dissociation from and association with 1 μM N∆17Arf1•GDP 
(left panel) or Rab5•GDP (right panel) after sequential addition of 10 mM EDTA 
followed by 20 mM MgCl2.  The initial [Mg2+] was 5 mM.  GTPase concentrations were 
maintained at a constant level by inclusion in the buffers for sequential mixing.  (B) Time 
courses for Mg2+ dissociation and nucleotide exchange for GDP bound forms of 
representative Arf (left panel) or Rab (right panel) family members after simultaneous 
addition of 10 mM EDTA and 10 μM GppNHp to GTPase solutions containing 5 mM 
MgCl2.  Black lines represent maximum likelihood fits with single (N∆13Arf6·GDP) or 
double exponential model functions.  (C) Annotated alignment of representative Arf and 
Rab sequences indicating the location of the tryptophan residues relative to the switch 
regions. 
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rapidly reversed the fluorescence decrease with a time constant less than the dead time of 
the instrument (1 ms), indicating that ka [Mg2+] >> kd and, consequently, ka > [Mg2+] / 
τmix = 105 s-1.   
 We next investigated whether the intrinsic tryptophan fluorescence of Arf and 
Rab GTPases from other classes/subfamilies is also sensitive to Mg2+ dissociation.  Based 
on sequence homology, the six mammalian Arf GTPases can be divided into three 
classes: Class I (Arf1, Arf2 and Arf3), Class II (Arf4 and Arf5) and Class III (Arf6).  
Since all classes of Arf GTPase have a 'hasp', through which the N-terminal helix 
stabilizes the inactive conformation of the interswitch region, equivalent constructs for 
Arf4 and Arf6 were generated with the N-terminal helix truncated.  Whereas two distinct 
exponential phases were observed for N∆17Arf1 and N∆17Arf4, only a single 
exponential phase was detected for N∆13Arf6 (Figure 3.4B).  The slow phase (or single 
phase for N∆13Arf6) was not observed in the absence of excess GppNHp (data not 
shown).  N∆17Arf1 and N∆13Arf6 have similar k-1' values of 6.4 × 10-3 s-1 and 4.7 × 10-3 
s-1 whereas that for N∆17Arf4 is ca. 5 fold higher (Table 3.3).  The kd values of 200 s-1 
and 83 s-1 for Mg2+ dissociation from N∆17Arf1 and N∆17Arf4 differ by less than 3 fold.  
The absence of a detectable Mg2+ dissociation phase for N∆13Arf6 is likely due to 
weaker Mg2+ binding resulting from perturbation of the Mg2+ coordination sphere by an 
isoleucine to serine substitution unique to Arf6 (18).  Consistent with this conclusion, 
addition of EDTA has a relatively small affect on kobs for GDP release from N∆13Arf6 
(Table 3.2). 
 104 
Table 3.3 Rate constants for Mg2+ equilibration and GDP/GppNHp exchange † 
 
 ka ‡ 
(M-1 s-1) 
 kd  * 
(s-1) 
 kobs1 * 
(s-1) 
 kobs2 * 
(× 10-3 s-1) 
N∆17Arf1 > 1 × 105 83 ± 9 83 ± 9 6.40 ± 0.01 
N∆17Arf4 N.D. N.D. 200 ± 10 32 ± 3 
N∆13Arf6 N.D. N.D. N.D. 4.65 ±0.20 
Rab1 N.D. N.D. 14.7 ± 0.3 5.35± 0.08 
Rab5 > 1 × 105 10.9 ± 0.9 10.9 ± 0.9 3.10± 0.04 
Rab6 N.D. N.D. 5.1 ± 0.2 1.75± 0.08 
Rab7 N.D. N.D. 3.0 ± 0.1 10.9± 0.28 
Rab11 N.D. N.D. 33  ± 2 1.88 ± 0.09 
‡ Conservatively estimated limits based on free [Mg2+] and 1 ms mixing time as described in the 
text.  
* Mean ± standard deviation of the maximum likelihood values obtained by fitting 3 independent 
data sets with single or double exponential functions as described in the text. 
† N.D., Not Determined. 
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The majority of Rab GTPases can be hierarchically organized into phylogenetic groups 
(PGs) that contain functionally distinct proteins in addition to subfamilies of similar 
isoforms (24).  Time courses of EDTA accelerated exchange reactions for Rab GTPases 
from five PGs exhibited bi-exponential kinetics (Figure 3.4B), with a fast phase that 
presumably corresponds to Mg2+ dissociation (k-1' ranging from 3 s-1 for Rab7 to 33 s-1 
for Rab11) followed by a slower phase that could be unambiguously assigned to GDP-
release limited nucleotide exchange on the basis of the requirement for excess GppNHp 
and close agreement with kobs obtained from the single exponential time course observed 
in the corresponding GDP/mant-GppNHp exchange reaction monitored by FRET (Table 
3.2). 
 Rab GTPases have two conserved tryptophan residues (Figure 3.4C) and for those 
investigated here only Rab7 has an additional tryptophan residue that might contribute to 
the observed signal.  Thus, it is likely that the variations in the magnitude and/or sign of 
the amplitudes for the fast and slow kinetic phases reflects either differences in the local 
environment of the conserved tryptophan residues, which has been observed for the 
interswitch tryptophan as a consequence of structural variability in the active 
conformation (25), or differences in the affinities for Mg2+, which would influence the 
fraction of Mg2+ bound in presence and absence of EDTA.  Additional experiments 
would be necessary to distinguish these possibilities and clarify the origin of the observed 
variation in intrinsic tryptophan fluorescence amplitudes.  Nevertheless, it is clear that 
while the exchange rates at low [Mg2+] are substantially faster than the exchange rates at 
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high [Mg2+], the apparent kd for Mg2+ release does not strictly correlate with the apparent 
k-1'. 
 
Nucleotide dependence of the GEF catalyzed exchange rate 
 The exchange activity of some Sec7 and Vps9 domain GEFs, including 
Cytohesins and Rabex-5, is strongly suppressed by autoinhibitory mechanisms involving 
intramolecular interactions with elements beyond the catalytic core (57, 112).  Therefore, 
to gain insight into the kinetic properties independent of autoregulatory elements, the 
exchange reactions catalyzed by the Sec7 domain of Cytohesin-1 and the HB-Vps9 
tandem of Rabex-5 were analyzed using N∆17Arf1 and Rab5 as substrates.  To increase 
the signal-to-background ratio for intrinsic tryptophan fluorescence experiments, the 
single tryptophan residues in the catalytic cores of Cytohesin-1 and Rabex-5 were 
mutated to phenylalanine.  There is no significant difference in the catalytic activity or 
oligomeric state of the wild type proteins and Trp to Phe mutants (Table 3.2).  
 Previous kinetic and thermodynamic analyses of structurally unrelated GEFs for 
several different GTPase families support the kinetic mechanism depicted by the linked 
equilibria in Figure 3.2, wherein the GEF and nucleotide compete for binding to the 
nucleotide free GTPase (46, 49, 51, 192).  In the absence of excess nucleotide, mixtures 
of free GEFs and GDP-bound GTPases rapidly equilibrate with ternary 
GEF•GTPase•GDP and nucleotide free binary GEF•GTPase complexes.  Depending on 
the values of K3 and K4 as well as the total concentrations of GEF and GTPase, the 
binary GEF•GTPase complex can be substantially populated, allowing the approach to 
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equilibrium to be monitored through fluorescence changes accompanying nucleotide 
release.  Addition of excess nucleotide (GXP) drives the equilibrium in the direction of 
nucleotide bound states, thereby reducing the amplitude of the signal associated with 
formation of the binary GEF•GTPase intermediate.  If [GDP] << [GXP] and the 
association rate constants k1 and k4 are not substantially larger for GDP than for GXP, the 
back reactions involving GDP rebinding can be neglected.  Under steady state conditions 
for both the binary and ternary intermediates, the exchange reaction will approach 
equilibrium following an exponential time course with an observed rate that can be 
equivalently expressed as 
kobs = (kcat(app) - k-1) φM + k-1                                              (3a) 
or 
kobs = {(k-4 - k-1) φM +  k-1} φng                                           (3b) 
where 
kcat(app) = k-4 φn                                                          (3c) 
KM(app) = KM φn                                                         (3d) 
KM = 
k-3 + k-4
k3
 = K3 + 
k-4
k3
                                                    (3e) 
KM2 = 
k-4 + k-2
k4
 = K4 + Kb                                                   (3f) 
φM = 
[GEF]
KM + [GEF]                                                           (3g) 
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φn = 
Kb + [GXP]
KM2 + [GXP]                                                           (3h) 
φng = 
Kb + [GXP]
Kg + [GXP]
                                                           (3i) 
Kb = 
k-2
k4
                                                                 (3j) 
Kg = K4 φM + Kb                                                         (3k) 
KM is the steady state (Michaelis) constant for the ternary intermediate, KM2 is an 
analogous steady state constant for the binary intermediate, Kb is a branching ratio for 
decay of the binary complex by dissociation vs. GXP binding, φM is the steady state yield 
or fractional population of the ternary intermediate relative to the total concentration of 
GDP bound species, φn and φng are functions describing the dependence on [GXP] alone 
or [GXP] and [GEF], respectively, and Kg is an apparent half maximal constant that 
depends on [GEF].  Whereas φM ranges hyperbolically from 0 to 1, the ratios φn and φng 
approach 1 in the limit [GXP]→∞ from values at [GXP] = 0 (Kb/KM2 and Kb/Kg, 
respectively) in the range from 0 to ∞ such that the dependence on [GXP] can be 
hyperbolic (Kb/KM2 or Kb/Kg < 1), constant (Kb/KM2 or Kb/Kg = 1) or inverse hyperbolic 
(Kb/KM2 or Kb/Kg > 1).  As a practical consequence of the dual dependence on [GEF] and 
[GXP], kobs for exchange reactions measured at constant [GXP] will also have a 
hyperbolic dependence on [GEF] with an apparent half maximal concentration KM(app) 
that only approaches KM in the limit [GXP] >> KM2.  Nevertheless, the catalytic 
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efficiency (k-4/ KM), which represents the bimolecular rate constant for the exchange 
reaction under conditions where nucleotide release is rate limiting and [GEF] and 
[GTPase] << KM, is equal the ratio kcat(app)/KM(app).  Finally, when [GEF] << KM, the 
expression for the observed rate constant reduces to 
kobs = k∞ 
Kb + [GXP]
Kg + [GXP]
                                                      (4a) 
where 
k∞ =
k-4 - k-1
KM  [GEF] + k-1                                                   (4b) 
Kg = 
K4
KM [GEF] + Kb                                                      (4c) 
If k-1 << k-4, as verified below for the GEF and GTPases examined here, Eqn 4b reduces 
further to 
k∞ =
k-4
KM [GEF] + k-1                                                    (4d) 
which corresponds to the expression widely used to analyze the catalytic efficiency of 
exchange reactions in the presence of a large excess of the replacing nucleotide. 
 For both the Cytohesin-1 Sec7 domain and Rabex-5 HB-Vps9 tandem, the 
approach to equilibrium in the absence of excess nucleotide follows an exponential time 
course for substrate GTPases loaded with mant-dGDP (blue traces in Figure 3.5).  When 
monitored by intrinsic tryptophan fluorescence, an exponential time course with a similar 
kobs was observed for the Cytohesin-1 Sec7 domain and N∆17Arf1•GDP.  Significant  
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Figure 3.5 Dependence of GEF mediated exchange kinetics on nucleotide  
  concentration.   
(A and B) Representative nucleotide release/exchange time courses for 0.5 μM 
N∆17Arf1 or Rab5 after simultaneous addition of 10 μM W150F Cytohesin-1 Sec7 
domain or 10μM W247F Rabex-5 HB-VPS9 tandem and the indicated concentration of 
GppNHp or GDP.  Black lines represent maximum likelihood fits with single or double 
exponential model functions as described in the text.  (A) Time courses of GEF-catalyzed 
nucleotide release/exchange for N∆17Arf1•mant-dGDP (upper panel) or Rab5•mant-
dGDP (lower panel) monitored by direct mant excitation.  (B) Time courses of GEF-
catalyzed nucleotide release/exchange for N∆17Arf1•GDP (upper panel) or Rab5•GDP 
(lower panel) monitored by intrinsic tryptophan fluorescence.  (C) Dependence of the 
observed rate constant for GEF-catalyzed nucleotide exchange (kobs2) on [GppNHp] using 
GDP or mant-dGDP loaded forms of N∆17Arf1 (upper panel) or Rab5 (lower panel as 
substrates).  Values of kobs2 were derived from the time course of GDP/GppNHp 
exchange reactions monitored by intrinsic tryptophan fluorescence or from mant-
dGDP/GppNHp exchange reactions monitored by direct mant excitation.  Black lines 
represent the maximum likelihood fits to Eqn 4a/4d as described in the text. 
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changes in the intrinsic tryptophan signal were not detected after mixing the Rabex-5 
HB-Vps9 tandem with Rab5•GDP.  The absence of a detectable intrinsic tryptophan 
fluorescence signal is consistent with the possibility that the binary complex may be 
weakly populated.  However, the invariant interswitch tryptophan of Rab21 is buried at 
the interface in the nucleotide free complex with the Rabex-5 HB-Vps9 tandem (57).  
Consequently, the decreased intrinsic tryptophan fluorescence associated with nucleotide 
release may be partially offset by increased fluorescence associated with binary and/or 
ternary complex formation.   
 At low to intermediate concentrations of excess GppNHp (red and brown traces in 
Figure 3.5A and 3.5B), the time courses for the reactions with mant-dGDP loaded 
GTPases as well as N∆17Arf1•GDP deviate from single exponential kinetics but are well 
fit by a bi-exponential function (Eqn 2) with kobs1 treated as a global parameter and a1, a2 
and kobs2 treated as local parameters (Figure 3.6).  As predicted by the competition 
between the GEF and nucleotides for binding to the nucleotide free GTPase (Figure 3.2), 
the amplitude of the faster phase decreases with increasing [GppNHp] while the 
amplitude of the slower phase increases.  At high [GppNHp] (purple traces in Figure 
3.5A and 3.5B), intermediate formation is no longer detectable and the exchange reaction 
proceeds to equilibrium with a single exponential time course.  At high [GDP] (green 
traces in Figure 3.5A and 3.5B), single exponential time courses, with kobs similar to 
those for the equivalent [GppNHp], are observed for mant-dGDP/GDP exchange whereas 
no change in the intrinsic tryptophan signal is observed, as expected for the GDP/GDP  
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Figure 3.6 Intermediate formation and GDP/GppNHp exchange for the  
  Cytohesin-1 Sec7 domain and N∆17Arf1 
(A and B) Representative time courses for nucleotide release/exchange for 0.5 μM 
N∆17Arf1•GDP after simultaneous addition of 10 μM W150F Cytohesin-1 Sec7 domain 
and the indicated concentration of GppNHp.  Experiments are monitored by intrinsic 
tryptophan fluorescence.  Black lines represent maximum likelihood fits with single or 
double exponential model functions as described in the text.  (C) GppNHp dependence of 
the fractional amplitudes associated with intermediate formation and nucleotide exchange 
for the Cytohesin-1 Sec7 domain and N∆17Arf1•GDP.  Amplitudes are maximum 
likelihood values derived from a fit with a biexponential function as described in the text.   
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exchange reaction.  Small deviations on a longer time scale may represent aggregation or 
instrumental drift and were not investigated further.  
 As shown in Figure 3.5C, the observed rate constant for the slower phase exhibits 
a hyperbolic dependence on [GppNHp], consistent with GDP release becoming rate 
limiting as [GppNHp] increases relative to [GEF].  The observed rate constants are well 
fit by Eqn 4a/4d, with k-4/KM and k4 treated as freely adjustable parameters, k-1 fixed at 
the value determined for the intrinsic reaction under identical conditions, and k-2 
neglected since its value was underdetermined and could not be distinguished from zero.   
Relatively small values for k-2 are not unexpected as GEFs typically form stable binary 
nucleotide free complexes with slow off rates (46).  Consistent with this expectation, 
systematic variation of k-2 while fitting k-4/KM and k4 revealed that the log likelihood 
function (χ2) increases quadratically from its value at k-2 = 0 s-1 to unacceptably high 
values (conservatively defined as reduced χ2 > 5) for k-2 > 0.1-0.5 s-1.   
 At 10 μM Cytohesin-1 Sec7 domain, similar values of k∞ (ca. 1.4 s-1) and Kg (ca. 
80 μM) were obtained for N∆17Arf1•mant-dGDP or N∆17Arf1•GDP as the substrate 
(Table 3.4).  At 10 μM Rabex-5 HB-Vps9 tandem, on the other hand, the k∞ differed by 
16 fold for Rab5•GDP (k∞ = 1.3 s-1) compared to Rab5•mant-dGDP (k∞ = 0.081 s-1) 
whereas Kg differed by a factor of three (37 μM vs. 12 μM, respectively).  Two kinetic 
phases, presumably related to slow isomerization of the methylanthraniloyl label between 
the 2' and 3' hydroxyl groups, were observed for the exchange reactions with mant-GDP  
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Table 3.4 Kinetic parameters for nucleotide dependence of GEF catalyzed exchanged  
  reactions  
 
 k4 ‡ 
(×104 M-1 s-1) 
 Kg ‡ 
(μM) 
 k∞ * 
(s-1) 
N∆17Arf1•mant-dGDP 2.0 ± 0.3 79.6 ± 8 1.6 ± 0.1 
N∆17Arf1•GDP 1.9 ± 0.2 83 ± 9 1.4 ± 0.1 
Rab5 •mant-dGDP 1.1 ± 0.1 12 ± 3 0.081 ± 0.003 
Rab5•GDP 3.6 ± 0.3 37 ± 3 1.32 ± 0.03 
‡ Mean ± standard deviation of the maximum likelihood values obtained by fitting Eqn 4a/4d to 3 
independent data sets, with k-4/KM and k4 treated as freely adjustable parameters, k-1 fixed at the 
value determined for the intrinsic reaction under identical conditions, and k-2 neglected.  
* Calculated with Eqn 4d using the maximum likelihood values for k-4/KM, [GEF] = 10 μM, and 
k-1 determined for the intrinsic reaction. 
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loaded substrates, which were not further characterized.  The affect of the mant label on 
the exchange kinetics catalyzed by the Rabex-5 HB-Vps9 tandem correlates with the 
affect on the intrinsic rate of nucleotide release and thus appears to derive from the 
interaction of the mant label with Rab5 as discussed above. 
 
Effect of GEF concentration on intermediate formation and exchange kinetics 
 The limit in which the exchange rate is determined solely by nucleotide release is 
approached when [GXP] >> Kg.  This condition is reasonably approximated (i.e. kobs 
within 10% of k∞) at [GXP] ≥ 10 × Kg.  Assuming that Kg is proportional to [GEF] over 
the range of interest (Eqn 4c), the minimum [GXP]/[GEF] ratio required to approximate 
saturation is ca. 90 for the Cytohesin-1 Sec7 domain and ca. 40 for the Rabex-5 HB-Vps9 
tandem.  This assumption is consistent with the observed nucleotide dependence at 1.5 
and 10 μM Cytohesin-1 Sec7 domain or 10 and 40 μM Rabex-5 HB-Vps9 tandem 
(Figure 3.7) and further validated by the linear dependence of the observed rate of 
nucleotide release/exchange on [GEF] as discussed below.  Considering that the mant 
group substantially perturbs the exchange kinetics for Rab5 but has negligible affect for 
N∆17Arf1, the dependence on [GEF] was characterized using N∆17Arf1•mant-dGDP 
and Rab5•GDP as substrates. 
 The observed rate constants in the absence of excess nucleotide or at a 
[GDP]/[GEF] ratio of 180 varied linearly with the concentration of the Cytohesin-1 Sec7 
domain over the experimentally accessible concentration range (Figure 3.8A).  Although 
the ternary Rabex-5 HB-Vps9 tandem•Rab5•GDP intermediate could not be detected by  
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Figure 3.7 Nucleotide dependence of GEF catalyzed exchange reactions  
  monitored by intrinsic tryptophan fluorescence  
(A) Left panel, representative time courses for 0.5 μM N∆17Arf1•GDP after 
simultaneous addition of 1.5 μM W150F Cytohesin-1 Sec7 domain and the indicated 
concentration of GppNHp.  Right panel, dependence of the observed exchange rate 
constant (kobs2) on [GppNHp].  (B) Left panel, representative time courses for 0.5 μM 
Rab5•GDP after simultaneous addition of 40 μM W247F Rabex-5 HB-Vps9 tandem and 
the indicated concentration of GppNHp.  Right panel, dependence of the observed 
exchange rate constant (kobs) on [GppNHp].  Black lines represent maximum likelihood 
models from fits with single (B) or double (A) exponential functions (left panels) or Eqn 
4a/4d (right panels) as described in the text. 
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Figure 3.8 Effect of GEF concentration on the kinetics of intermediate formation 
  and nucleotide exchange.   
(A) Left panel, representative nucleotide release/exchange time courses for 0.5 μM 
N∆17Arf1•mant-dGDP catalyzed by the W150F Cytohesin-1 Sec7 domain in absence of 
excess nucleotide or presence of 180 fold excess GDP ([GDP] = 180 × [GEF]) monitored 
by mant fluorescence.  Right panel, dependence of the observed rate constant for 
N∆17Arf1•mant-dGDP release/exchange on the concentration of the W150F Cytohesin-1 
Sec7 domain in the absence of excess nucleotide or at a fixed ratio of [GDP] = 180 × 
[GEF].  (B) Left panel, representative nucleotide exchange time courses for 0.5 μM 
Rab5•GDP catalyzed by the W247F Rabex-5 HB-Vps9 tandem in absence of excess 
nucleotide or presence of 40 fold excess GppNHp ([GDP] = 40 × [GEF]) monitored by 
intrinsic tryptophan fluorescence. Right panel, dependence of the observed rate constant 
for Rab5 GDP/GppNHp exchange on the concentration of the W247F Rabex-5 HB-VPS9 
tandem in the presence of a fixed ratio of [GppNHp] = 40 × [GEF]. Black lines represent 
maximum likelihood or linear least squares models as described in the text.   
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intrinsic tryptophan fluorescence, the observed exchange rate constant at a 
[GppNHp]/[GEF] ratio of 40 varied linearly with the concentration of the Rabex-5 HB-
Vps9 tandem over entire concentration range (Figure 3.8B).  Practical considerations, 
including inner filter effects and solubility, prevented measurements at higher GEF 
concentrations.  Nevertheless, conservative lower limits can be placed on the values of k-4 
and KM.  Thus, k-4 > 16 s-1 and KM > 100 μM for the Cytohesin-1 Sec7 domain whereas 
k-4 > 11 s-1 and KM > 100 μM for the Rabex-5 HB-Vps9 tandem.  Catalytic efficiencies 
(k-4/KM) of 1.3 × 105 M-1 s-1 for the Cytohesin-1 Sec7 domain and 1.1 × 105 M-1 s-1 for 
the Rabex-5 HB-Vps9 tandem, obtained by linear least squares using Eqn 4d, agree well 
with the values obtained by analyzing the dependence on [GppNHp] (Table 3.5).  Rate 
and steady state constants for the intrinsic and GEF catalyzed exchange reactions for the 
Cytohesin-1 Sec7 domain, Rabex-5 HB-Vps9 tandem and other previously characterized 
GEFs are compared in Table 3.6. 
 As an alternative approach, the dependence on [GEF] was characterized by 
monitoring the FRET signal at a fixed [mant-dGppNHp] of 10 μM (Figure 3.9).  The 
observed rate constant depends hyperbolically on [GEF] and is well described by a fit to 
Eqn 3a with kcat(app) and KM(app) treated as adjustable parameters and k-1 restrained by the 
value determined for the intrinsic exchange reaction under identical conditions.  For 
Rabex-5 HB-Vps9 tandem, the maximum likelihood values of kcat(app) and KM(app) are 
similar to the predicted values obtained by fitting Eqn 3a to a simulated data set 
calculated from Eqn 4a (with k-2 neglected as discussed above) using the values of  
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Table 3.5 Comparison of catalytic efficiencies (k-4/KM) obtained by different methods 
Method 
k-4/KM 
(× 105 s-1) Figure 
N∆17Arf1•mant-dGDP + 10 μM Sec7 + varying [GppNHp] 1.6 ± 0.1 ‡ 3C 
N∆17Arf1•mant-dGDP + varying [Sec7] + [GDP] = 180 fold × [Sec7]  1.3 ± 0.1 * 4B 
N∆17Arf1•GDP + varying [Sec7] + 10 μM mant-dGppNHp 0.27 ± 0.02 ‡ 4C 
Rab5•GDP + 10 μM HB-Vps9 + varying [GppNHp] 1.32 ± 0.03 ‡ 3C 
Rab5•GDP + varying [HB-Vps9] + [GppNHp] = 40 fold × [HB-Vps9] 1.06 ± 0.06 * 4B 
Rab5•GDP + varying [HB-Vps9] + 10 μM mant-dGppNHp 1.0 ± 0.2 ‡ 4C 
‡ Mean ± standard deviation of the maximum likelihood values obtained by fitting Eqn 4a/4d to 3 
independent data sets, with k-4/KM and k4 treated as freely adjustable parameters, k-1 fixed at the 
value determined for the intrinsic reaction under identical conditions, and k-2 neglected.  
* Mean ± standard deviation of the linear least squares values for n = 3.  
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Table 3.6 Comparison of kinetic parameters for different GEF: GTPase systems 
GEF:GTPase k-1 k-1' k-4 KM k-4/k-1 k-4/KM Reference 
 (s-1) (s-1) (s-1) (μM)  (M-1 s-1)  
Sec7 CD:Arf1NT 1.4×10-4 7.1×10-3 >16 >100 >1.1×105 1.3×105 This study 
HB-VPS9CD:Rab5FL 5.8×10-5 3.1×10-3 >10 >100 >1.7×105 1.1×105 This study 
RCC1FL:RanFL 2.3×10-5 N.D. 21 0.7 9×105 3.0×107 (49) 
Sec2CD:Sec4GD 6.3×10-4 N.D. 15.3 77 2.4×104 2.0×105 (45) 
Cdc25CD:H-RasFL 1.2×10-5 N.D. 1.78 38 1.5×105 4.7×104 (51, 190) 
MSS4FL:Rab8FL 7.2×10-4 N.D. 0.23 27 320 8.5×103 (94) 
TrappCD:Ypt1GD 1.2×10-4 7.3×10-3 0.17 4.8 2.4×103 3.5×104 (189) 
Vps9FL:Ypt51FL 2×10-5 N.D. 0.01 23 6 ×102 5.2×102 (46) 
CD, catalytic domain; FL, full length; GD, GTPase Domain; N.D., Not Determined; NT, N-
terminus truncated 
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Figure 3.9 Effect of GEF concentration on the kinetics of 10 μM mant-dGppNHp 
  exchange monitored by Trp to mant fluorescence. 
Left panel, representative nucleotide exchange time courses for 0.5 μM N∆17Arf1• GDP 
or Rab5•GDP catalyzed by the W150F Sec7 or W247F HB-Vps9 domain at a fixed 
[mant-dGppNHp] of 10 μM monitored by Trp to mant fluorescence.  Right panel, 
dependence of the observed rate constant for GDP/mant-dGppNHp exchange on the 
concentration of the W150F Sec7 domain or W247F HB-Vps9 tandem at a fixed [mant-
dGppNHp] of 10 μM.  Black lines represent maximum likelihood or linear least squares 
models as described in the text.   
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k-4/KM, Kg, k4 and k-1 obtained from the experiments varying [GppNHp] in Figure 3.5C.  
Moreover, as expected from the form of Eqns 3c and 3d, the observed kcat(app)/KM(app) 
ratio of 1.0 × 105 M-1 s-1 is in good agreement with the value of k-4/KM determined by 
varying either [GppNHp] or [HB-Vps9] at a [GppNHp]/[ HB-Vps9] ratio of 40 (Table 
3.5).  However, kcat(app)/KM(app) ratio of 0.27 × 105 M-1 s-1 for the Cytohesin-1 Sec7 
domain is 5 fold lower than that obtained by the other methods.  The lower value for 
kcat(app)/KM(app) for the Cytohesin-1 Sec7 domain is not unexpected and can be attributed 
to the breakdown of the steady state condition for the GEF•G intermediate at lower 
concentrations of the replacing nucleotide (Figure 3.5). 
 
Simulation of nucleotide dependence in GEF catalyzed exchange  
 In figure 3.5A and 3.5B, we reported that the single exponential exchange kinetics 
catalyzed by a fixed concentration of Cytohesin-1 Sec7 domain become biphasic at low 
concentrations of displacing nucleotide.  It is unlikely that the bi-phasic kinetics are due 
to a trivial possibility such as heterogeneity in either GTPase/enzyme or protein 
aggregation over time as repeating the same experiment setup but monitoring by Trp to 
mant-dGppNHp FRET give single exponential exchange kinetics (data not shown). We 
proposed that Cytohesin-1 Sec7 domain and Rabex-5 HB-Vps9 tandem catalyze 
nucleotide exchange via the commonly accepted linked equilibrium depicted in figure 3.2 
and that bi-phasic kinetics at low [GppNHp] can arise from accumulation of the GEF•G 
intermediate due to rapid equilibrium.  To determine if this interpretation is reasonable, 
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we used TENUA (193), a kinetic simulation program that numerically solves the 
differential equations from scheme 2, to simulate the observed Arf1•dmant to GppNHp 
exchange kinetics mediated by Cytohesin-1 Sec7 domain with 5 μM GppNHp.  Using 
both the published elementary rates for other GEF and GTPase systems, the k-4 and KM 
limits we obtain in figure 3.8, and ignoring the slow off pathway formation of active 
GTPase through k-2 and k1, we can model the bi-phasic exchange kinetics in figure 3.5A 
very well (Figure 3.10 and Table 3.7).  Interestingly, a k-3 value higher than that reported 
for RCC1 and Cdc25 is required for modeling the experimental data. This is likely 
because Cytohesin-1 Sec7 domain is found to have a high KM < 100 μM as compared to 
0.7 μM for RCC1 and 38 μM for Cdc25 for the cognate GTPase.  The possibility of mant 
interacting with Rab5 and the failure of intrinsic tryptophan to detect intermediate 
formation between Rab5 and Rabex-5 HB-Vps9 tandem makes simulation even harder 
for this system.  However, the small amount of intermediate formed by Rab5 and Rabex-
5 HB-Vps9 tandem, and the similarly high kcat and KM values for the Rabex-5 HB-Vps9 
tandem and the Cytohesin-1 Sec7 domain, suggests that the k3 or k4 value for GDP is 
smaller for the HB-Vps9 tandem/Rab5 system than the Sec7:Arf1 system.  
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k3(mdGDP) = 1!107 M-1s-1 
GEF•G•GppNHp 
G•mdGDP 
GEF•G•mdGDP 
GEF•G 
G•GppNHp 
k-3(mdGDP) " 980 s-1 
k4(mdGDP) = 2!106 M-1s-1 k-4(mdGDP) " 20 s-1 
k4(GppNHp) = 2!104 M-1s-1 k-4(GppNHp) " 6 s-1 
k3(GppNHp) = 1!106 M-1s-1 k-3(GppNHp) " 994 s-1 
 
 
Figure 3.10 Kinetic scheme and parameters used in the simulation for the   
  Cytohesin-1 Sec7 domain mediated N∆17Arf1•mant-dGDP exchange.   
G, N∆17Arf1; GEF, Cytohesin-1 Sec7 domain; mdGDP, 3'-mant-2'-deoxy GDP.  
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Table 3.7 Comparison of experimental and simulated kinetic parameters for different GEF:  
  GTPase systems 
 
Experiment 
Sec7/Arf1NT 
with 5 μM 
GppNHP 
RCC1FL/ 
RanFL 
Cdc25CD/ 
H-RasFL 
Simulation 
Sec7/ Arf1NT 
with 5 μM 
GppNHP 
Simulation 
Sec7/Arf1NT 
with 5 μM  
GppNHP 
k3 
mdGDP 
(M-1 s-1) 
N.D. 7×107 7.2×105 1×107 1×107 
k-3 
mdGDP 
(s-1) 
N.D. 55 49 980 4900 
k-4 
mdGDP 
(s-1) 
< 16 21 1.78 20 100 
k4 
mdGDP 
(M-1 s-1) 
N.D. 1.1×107 3.8×106 2×106 2×106 
k4 
GXP 
 (M-1 s-1) 
N.D. 6.5×105 N.D. 2×104 2×104 
k-4 
GXP 
 (s-1) 
N.D. 19 N.D. 6 30 
k-3 
GXP 
 (s-1) 
N.D. 55 N.D. 994 4700 
k3 
GXP 
 (M-1 s-1) 
N.D. 1×108 N.D. 1×106 1×106 
kobs1 
(s-1) 
2.44 
 
N.D. N.D. 2.88 2.97 
Amplitude 1 
(arb.units) 
3.3×10-­‐7 N.D. N.D. 3.6×10-­‐7 3.6×10-­‐7 
kobs2 
(s-1) 
0.11 N.D. N.D. 0.12 0.13 
Amplitude 2 
(arb.units) 
6×10-­‐8 N.D. N.D. 7×10-­‐8 7×10-­‐8 
The concentration of N∆17Arf1•mant-dGDP is 0.5 μM and the concentration of Cytohesin-1 
Sec7 domain is 10 μM.  5 μM GppNHP is used as the displacing nucleotide in the actual 
Cytohesin-1 Sec7 domain mediated exchange and the simulated experiments. The displacing 
nucleotide in RCC1:Ran system is 3'-mant-2'-deoxy GTP. 
 
CD, catalytic domain; FL, full length; mdGDP, 3'-mant-2'-deoxy GDP; GXP, any nucleotide; 
N.D., Not determined; NT, N-terminus truncated; Sec7, Cytohesin-1 Sec7 domain. 
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Mg2+ dependence of GEF catalyzed nucleotide release 
 To assess the ability of the Cytohesin-1 Sec7 domain and Rabex-5 HB-Vps9 
tandem to catalyze nucleotide release at low [Mg2+], GTPases were first mixed with 10 
mM EDTA and subsequently mixed with GEF + 10 mM EDTA to yield a final free 
[Mg2+] of 0.16 μM.  As shown in Figure 3.11, addition of EDTA results in negligible 
fluorescence change for N∆17Arf1•mant-dGDP and a rapid decrease in intrinsic 
tryptophan fluorescence for Rab5•GDP, which is due to Mg2+ release as discussed above.  
Apart from the rapid decrease in intrinsic Rab5•GDP fluorescence due to Mg2+ release, 
the fluorescence signals remain constant for at least 30 min, indicating that Mg2+ release 
occurs without significant nucleotide dissociation. 
 In the absence of a replacing nucleotide, the time course for formation of the 
binary GEF•G intermediate for the Cytohesin-1 Sec7 domain and N∆17Arf1•mant-dGDP 
at low [Mg2+] is well described by an single exponential function (Figure 3.12A).  The 
observed rate constants vary linearly with [GEF] over the experimentally accessible 
range.  The catalytic efficiency (k-4'/ KM'  = 9.2 × 105 M-1 s-1) is 7 fold faster than that at 
physiological [Mg2+] (Table 3.8).  The increase in catalytic efficiency at low [Mg2+] can 
be attributed to decreased nucleotide affinity, which allows the GEF to compete more 
effectively for the nucleotide free GTPase.  For the reaction with Rab5•GDP in the low 
[Mg2+] condition, the intrinsic tryptophan fluorescence increases substantially after  
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Figure 3.11 Time courses after addition of EDTA to N∆17Arf1•mant-dGDP and 
  Rab5•GDP  
(A) Time course after mixing 0.5 μM N∆17Arf1•mant-dGDP with 10 mM EDTA or 1.5 
μM W150F Cytohesin-1 Sec7 domain and 0.2 mM GDP.  (B) Time course after mixing 
0.5 μM Rab5•GDP with 10 mM EDTA.  All GTPases were diluted in buffer containing 
2.5 mM Mg2+.  Black lines represent maximum likelihood models from fits with a single 
exponential function as described in the text. 
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Figure 3.12 Mg2+ dependence of GEF catalyzed nucleotide release 
(A) Left panel, representative nucleotide release/exchange time courses for 0.5 μM 
N∆17Arf1•mant-dGDP catalyzed by the W150F Cytohesin-1 Sec7 domain at 0.16 μM 
Mg2+.  Right panel, observed rate constant for N∆17Arf1•mant-dGDP release at 0.16 μM 
and 5 mM Mg2+ as a function of [W150F Cytohesin-1 Sec7 domain] in the absence of 
replacing nucleotide.  (B) Left panel, representative nucleotide release/exchange time 
courses for 0.5 μM Rab5•GDP catalyzed by the W247F Rabex-5 HB-Vps9 tandem at 
0.16 μM Mg2+ monitored by intrinsic tryptophan fluorescence.  Right panel, dependence 
of the observed rate constant for Rab5•GDP release/exchange at 0.16 μM or 5 mM Mg2+ 
as a function of [W247F Rabex-5 HB-VPS9 tandem] in the absence of replacing 
nucleotide or at a fixed ratio of [GppNHp] = 40 × [GEF].  Black lines represent 
maximum likelihood or linear least squares models as described in the text.  
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Table 3.7 Catalytic efficiencies and fold acceleration at physiological and low [Mg2+] 
GEF:GTPase k-4/Km ‡ k-4'/Km'  * (k-4/Km) / k-1 (k-4'/Km') / k-1' 
 (× 105 M-1 s-1) (× 105 M-1 s-1) (× 108 M-1) (× 108 M-1) 
Sec7:Arf1•mant-dGDP 1.3 ± 0.1 9.2 ± 1.2 9.3 1.3 
HB-Vps9:Rab5•GDP 1.06 ± 0.06 5.2 ± 0.4 18 1.7 
‡ Values from from Table 3.5 
* Mean ± standard deviation of the values from a linear least squares fit to 3 independent data sets 
(Cytohesin-1 Sec7 domain) or the maximum likelihood values from a fit of Eqn 3a/i to 3 
independent data (Rabex-5 HB-Vps9 tandem). 
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mixing with 10 μM Rabex-5 HB-Vps9 tandem in the absence of replacing nucleotide 
(Figure 3.12B).  The time course is well described by a bi-exponential function, with a 
fast phase that accounts for >80% of the total amplitude followed by a distinct slow 
phase.  The fast phase likely represents formation of the binary HB-Vps9 tandem•Rab5 
intermediate, which would be expected to accumulate to detectable levels at low [Mg2+] 
as a consequence of the large decrease in GDP affinity.  The origin of the slow phase is 
less clear, but may be related to conformational heterogeneity in the ternary intermediate 
or possibly an off pathway species.  In the presence of 400 μM GDP, the amplitude of 
both phases is substantially diminished whereas the observed rate constants are largely 
unaffected, as expected when GDP release is rate limiting.  In contrast, the observed rate 
constant for the fast phase in the absence of excess replacing nucleotide increases with an 
apparently hyperbolic dependence on [HB-Vps9 tandem].  Although the maximum 
likelihood values of k-4' and KM' are substantially correlated due to lack of saturation, the 
catalytic efficiency for GDP release (k-4'/KM' = 5.2×105 M-1 s-1) is well determined and is 
5 fold higher at low [Mg2+].  Finally, when Rab5•GDP is mixed with 10 μM Rabex-5 
HB-Vps9 tandem and 400 μM GppNHp, the amplitude of the fast phase diminishes while 
an additional slow phase of opposite sign is observed, which can be assigned to 
equilibration with the Rab5•GppNHp species.  In the absence of Mg2+ to trap the 
GppNHp bound species, the back reactions can not be neglected and consequently the 
observed rate constant for equilibration with Rab5•GppNHp is considerably slower than 
the exchange rate constant at 5 mM Mg2+. 
 131 
 To address whether disruption of the Mg2+ binding site contributes to the kinetics 
of nucleotide release for the Cytohesin-1 Sec7 domain and/or the Rabex-5 HB-Vps9 
tandem, the ratio of the catalytic efficiencies to the intrinsic rate constants were compared 
at high and low [Mg2+].  For the Cytohesin-1 Sec7 domain, (k-4/KM) / k-1 of 9.3 × 108 M-1 
at 5 mM Mg2+ is 7 fold greater than the (k-4'/KM') / k-1' of 1.3 × 108 M-1 at low [Mg2+].  
Likewise, for the Rabex-5 HB-Vps9 tandem, the (k-4/KM) / k-1 of 1.9 × 109 M-1 at 5 mM 
Mg2+ is 11 fold greater than the (k-4'/KM') / k-1' of 1.7 × 108 M-1 at low [Mg2+].  These 
observations suggest that disruption of Mg2+ binding contributes to the acceleration of 
nucleotide release by the catalytic cores of both GEFs. 
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Discussion 
 In this study, we investigated the kinetic mechanism for acceleration of nucleotide 
exchange by the catalytic cores of Cytohesin-1 and Rabex-5 which, despite having 
unrelated folds, share a common mode of interaction with cognate GTPases, supply an 
acidic residue that stabilizes the nucleotide free intermediate through interaction with the 
invariant P-loop lysine, and are subject to autoregulation.  The exchange kinetics after 
stopped flow mixing were continuously monitored by three complementary fluorescence 
readouts allowing detection of Mg2+ equilibration, nucleotide release, intermediate 
formation, and nucleotide binding.  Using this approach, kinetic constants for the intrinsic 
and catalyzed exchange reactions could be determined, validated and controlled for the 
effects of extrinsic labels at physiological as well as low Mg2+ concentrations.  The 
dependence of the observed exchange rate constant on nucleotide and GEF concentration 
could be fully and quantitatively analyzed in the context of the simplest reaction scheme 
based on the generally accepted allosteric competition mechanism, with biphasic kinetics 
attributable to accumulation of the binary nucleotide free intermediate.  Notably, analysis 
of the reaction kinetics using a dual steady state solution for the binary and ternary 
intermediates revealed that, at the intermediate nucleotide concentrations used in the 
FRET experiment, saturation of the observed exchange rate constant at high GEF 
concentrations is not due to saturation of the ternary intermediate but instead reflects a 
change in the rate limiting step, from formation of the binary intermediate by nucleotide 
release at low GEF concentrations to decay of the binary intermediate by nucleotide 
binding at high GEF concentrations.  Under conditions favoring accumulation of the 
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binary intermediate, the dual steady state assumption breaks down and the approach to 
equilibrium slows further, suggesting that the back reactions become rate limiting. 
 Mant-nucleotides bound to GTPases typically have 2-3 fold higher fluorescence 
than in solution (48, 50), can be directly excited at wavelengths where protein absorbance 
and excitation of intrinsic fluorophores is relatively low, can serve as acceptors for FRET 
from intrinsic tryptophan donors, and have been widely used to monitor the kinetics of 
intrinsic as well as GEF-accelerated nucleotide association and dissociation reactions.  
The 2' and 3' mant isomers can, however, exhibit differences in exchange kinetics (51, 
189) and, consequently, the suitability of mant-nucleotides for detailed kinetic analyses 
must be evaluated in each instance.  The mant label has no discernable effect on the 
exchange kinetics for N∆17Arf1 in either the intrinsic reaction or in the reaction 
catalyzed by the Cytohesin-1 Sec7 domain but substantially impedes the rate of GDP 
release from Rab5 by 3-15 fold, depending on whether it is attached to the 2' or 3' 
hydroxyl and, to a lesser extent, whether the exchange reaction is monitored in the 
presence or absence of the Rabex-5 HB-Vps9 tandem.  For this reason, the kinetic 
parameters for exchange reactions involving Rab5 were derived from intrinsic tryptophan 
fluorescence experiments. 
 Mg2+ is required for high affinity nucleotide binding and GTP hydrolysis (47, 
194).  For N∆17Arf1 and Rab5, removing Mg2+ by addition of EDTA increases the rate 
of intrinsic nucleotide exchange by 50 fold (k-1'/k-1).  In contrast, the Cytohesin-1 Sec7 
domain and Rabex-5 HB-Vps9 tandem can accelerate nucleotide exchange by at least 
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five orders of magnitude (k-4/k-1), indicating that these GEFs do not simply prevent Mg2+ 
binding but instead promote conformational rearrangements to facilitate nucleotide 
release.  Structures of Sec7 and HB-Vps9 domain complexes with GDP bound as well as 
nucleotide free forms of cognate Arf and Rab GTPases suggest that the structural 
rearrangements underlying the dramatic acceleration of nucleotide release involve 
displacement of the switch I region away from the nucleotide site to facilitate GDP egress 
in addition to remodeling of the P-loop and switch II region in the vicinity of the 
phosphate/Mg2+ region (57, 88, 92, 188).  Unlike acceleration by EDTA, however, a 
distinct phase for Mg2+ release was not detectable in the GEF catalyzed reactions, 
suggesting that Mg2+ and GDP release are either concerted or that GDP release occurs 
rapidly after rate limiting Mg2+ release. 
 GEF catalyzed exchange reactions typically proceed through formation of a 
transient ternary GEF•GTPase•GDP intermediate, which relaxes to a more stable binary 
nucleotide free GEF•GTPase complex (46, 49, 51, 192).  Although we did not observe a 
distinct kinetic phase for the formation of ternary Sec7•Arf1•GXP or VPS9•Rab5•GXP 
complexes, these intermediates must be populated at least transiently in solution and have 
been trapped at high effective concentrations in crystalline lattices (88, 188).  At low 
nucleotide concentrations, however, we did observe an intermediate for the Cytohesin-1 
Sec7 domain and N∆17Arf1 that likely corresponds to the binary complex or a rapidly 
equilibrating mixture of the binary and ternary complexes.  At low Mg2+ and nucleotide 
concentrations, an analogous intermediate was detected for complexes of both the 
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Cytohesin-1 Sec7 domain and Rabex-5 HB-Vps9 tandem with cognate GTPases.  The 
enhanced ability to detect intermediates at low [Mg2+] is consistent with the lower 
affinity and higher off rate for GDP in the absence of Mg2+, which favors formation of 
the nucleotide free complex at the expense of the nucleotide bound states. 
 GEFs are structurally diverse, vary in complexity from small proteins to 
complexes with multiple subunits, and exhibit a broad range of catalytic efficiencies for 
GTPase substrates.  In the case of Rabex-5 and Cytohesins, the output of the catalytic 
core is suppressed by intramolecular interactions with autoinhibitory elements.  To gain 
insight into the catalytic properties in the absence of these autoinhibitory interactions, we 
performed a detailed kinetic analysis of the isolated exchange domains with respect to 
cognate GTPase substrates.  Table 3.6 summarizes the resulting kinetic constants in the 
context of several well characterized GEFs for small GTPases.  Although practical 
considerations prevented determination of specific values for k-4 (the rate constant for 
GDP release from the ternary GEF•GTPase•GDP intermediate) and KM (the steady state 
constant for formation and decay of the ternary GEF•GTPase•GDP intermediate), it is 
clear from the conservative lower limits that k-4 for the Cytohesin-1 Sec7 domain and 
Rabex-5 HB-Vps9 tandem must be in the upper range, similar to or greater than that for 
RCC1 or Sec2p.  KM also falls in the upper range, similar to or greater than that reported 
for Sec2p.  Moreover, the Cytohesin-1 Sec7 domain and Rabex-5 HB-Vps9 tandem are 
evidently capable of accelerating the rate GDP dissociation by more than five orders of 
magnitude (i.e. k-4/k-1 > 105).  The catalytic efficiencies (k-4/KM), which could be 
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precisely determined by multiple methods, are strikingly similar for the Cytohesin-1 Sec7 
domain and Rabex-5 HB-Vps9 tandem, with values in the intermediate range similar to 
that for Sec2p.  Overall, these observations are consistent with the cellular contexts in 
which these GEFs operate.  Indeed, the Sec2p, Vps9 and Sec7 domain GEFs are recruited 
to membranes, where they activate membrane-associated GTPases to facilitate vesicular 
budding, transport, and tethering.  Co-localization on membranes restricts the volume 
available for diffusion and can enhance the effective concentrations of GEFs and GTPase 
by several orders of magnitude.  The high KM values for these membrane-targeted GEFs 
may therefore reflect selective pressure to minimize basal activation and thereby support 
robust spatial-temporal control over catalytic output.  RCC1, on the other hand, activates 
Ran in the nuclear cytoplasm in conjunction with nuclear import and thus may require a 
lower KM for efficient activation (45).   
 Cytohesins contain a PH domain that binds PtdIns(3,4,5)P3 with nM affinity and a 
polybasic motif that further enhances plasma membrane targeting (112, 147, 195) in 
addition to an acidic residue that reduces basal membrane association mediated by 
anionic phospholipids including PtdIns(4,5)P2 (196).  Rabex-5 is targeted to endosomes 
through multipartite interactions involving N-terminal ubiquitin binding domains, a 
membrane targeting region that binds Rab22, and a C-terminal helical region that binds 
the Rab-5 effector Rabaptin-5 (197, 198).  Interestingly, some of these membrane 
targeting domains also play an additional regulatory role.  The C-terminal amphipathic 
helix/polybasic motif of cytohesins, along with the Sec7-PH linker, directly blocks the 
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Arf substrate binding site in the Sec7 domain.  Phosphoinositide-dependent Arf6 binding 
relieves autoinhibition (112).  Rabex-5 is likewise autoinhibited by the C-terminal 
amphipathic helix.  Autoinhibition is partially relieved by Rabaptin-5 binding (57).  The 
detailed kinetic studies presented here assess the catalytic potential of the exchange cores 
and provide a framework for future studies to understand the kinetic properties of the full 
length proteins in the context of membranes, autoregulatory partners, and post-
translational modifications. 
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Experimental Procedures 
Constructs 
 Constructs were amplified with Vent polymerase (New England Biolabs) and 
cloned into the BamHI and SalI sites of a modified pET15b vector (Novagen) 
incorporating an N-terminal 6×His tag (MGHHHHHHGS) (Table 3.9).  Site-specific 
mutants were generated using the QuickChange kit (Stratagene).  All constructs were 
verified by sequencing the entire coding region. 
 
Expression and Purification 
 BL21(DE3)RIL (Stratagene) cells were transformed with expression plasmids, 
grown to OD600 of 0.4 in 2×YT-amp (16 g bacto tryptone, 10 g bacto yeast extract, 5 g 
NaCl, and 100 mg ampicillin per liter), and induced with 50 μM IPTG for 16 h at 20°C.  
Cells were disrupted by sonication after suspension for 30 min on ice in 50 mM Tris, pH 
8.0, 150 mM NaCl, 0.1% β-mercaptoethanol, 1 mM phenylmethanesulfonyl fluoride, 1 
mg/mL lysozyme, and 10 μg/mL protease-free DNase I (Worthington).  Triton X-100 
was added to a final concentration of 0.5% and the lysate centrifuged at 35000×g for 60 
min.  The clarified supernatants were loaded onto a Ni-NTA column (GE Healthcare) 
equilibrated with buffer A (50 mM Tris, pH 8.0, 150 mM NaCl, and 0.1% β-
mercaptoethanol), washed with 20 column volumes of buffer A containing 15 mM 
imidazole, and eluted with a gradient from 15 to 500 mM imidazole.  For GTPases, all 
buffers were supplemented with 5 mM MgCl2.  Subsequent ion exchange 
chromatography on HiTrap Q HP or HiTrap SP HP (GE Healthcare) followed by gel  
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Table 3.9 List of constructs  
 Species Accession Number Residue Number 
Arf1 Bovine BC140532 18-180 
Arf4 Human NM_001660 18-180 
Arf6 Human NM_001663 14-175 
Cytohesin-1 Human NM_004762 53-244 
Rab1A Human NM_004161 2-205 
Rab5A Human BC001267 1-215 
Rab6A Mus NM_001163663 2-208 
Rab7A Mus NM_009005 2-207 
Rab11A Human NM_004663 2-216 
Rabex-5 Human NM_014504 132-391 
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filtration chromatography over Superdex-75 or Superdex-200 (GE Healthcare) yielded 
protein preparations that were >99% pure as judged by SDS−PAGE. 
 
Nucleotide Loading 
 Nucleotide present in the purified GTPases (1 mg/mL) was exchanged by 
incubating with a 10-fold excess of GDP, GppNHp, mant-GDP, mant-dGDP or mant-
dGppNHp (Jena Bioscience) for 12 hrs at 25°C in 20 mM Tris, pH 7.5, 150 mM NaCl, 
and 5 mM EDTA.  After supplementing with 10 mM MgCl2, unbound nucleotide was 
removed by gel filtration chromatography over Superdex-75. 
 
Stopped flow kinetics  
 Stopped flow kinetic experiments were carried out in a buffer containing 50 mM 
Tris, pH 7.5, 5 mM MgCl2, 150 mM NaCl and 1 mM dithiothreitol at 30°C except as 
stated otherwise.  The kinetic time courses were measured in a SX20 stopped-flow 
apparatus (Applied Photophysics).  Stated concentrations correspond to the final values 
after mixing.  Fluorescence from intrinsic tryptophan residues was detected through a 320 
nm long pass filter following excitation at 290 nm.  Fluorescence from mant nucleotides 
was detected through a 400 nm long pass filter following either direct excitation at 365 
nm or FRET from intrinsic tryptophan residues excited at 290 nm.  Data collection was 
performed with software supplied by Applied Photophysics.  Local and global maximum 
likelihood analyses using Marquardt and Simplex algorithms were done with the in house 
program DELA.  Values reported are mean ± standard deviation for three independent 
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experiments unless stated otherwise.  For GEF mediated nucleotide exchange at low 
[Mg2+], GTPases were initially incubated with 10 mM EDTA at 30°C for 20 mins and 
subsequently mixed with GEFs in the presence or absence of nucleotides.  
MAXCHELATOR (http://www.stanford.edu/~cpatton/webmaxc/webmaxcS.htm) was 
used to calculate the final free Mg2+ concentrations. 
 
Kinetic Simulation   
 TENUA (http://bililite.nfshost.com/tenua/) is used to simulate the observed 
exchange kinetics using the kinetic parameters as described in the results.    
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CHAPTER IV 
 
Discussion 
 The previous chapters investigated the autoinhibitory and activation mechanisms 
in the Cytohesin family of Arf GEFs, and compared the kinetic mechanism for nucleotide 
exchange by the catalytic cores of Cytohesin-1 and Rabex-5. In this chapter, the main 
findings and implications will be discussed in practical as well as physiological contexts 
to benefit those who are interested in mechanisms of activation for small GTPases.  
Potential directions for further investigation will also be considered. 
 
Mechanism for nucleotide exchange and practical implications 
 The spatial and temporal control of vesicle trafficking from donor to acceptor 
membranes depends on the activation of Arf and Rab GTPases.  Kinetic, thermodynamic 
and structural analyses of GEFs for different GTPase families support an allosteric 
competition mechanism for acceleration of nucleotide exchange, whereby GEFs disrupt 
the Mg2+/phosphate binding site and compete with nucleotides for binding to the 
GTPases (45, 46, 49, 51).  Activation is completed by the reverse process in which GTP 
and Mg2+ compete with the GEF for binding to the nucleotide free form of the GTPase.  
A consequence of this coupled equilibrium is that the relative affinity and concentration 
of each species can dictate which steps in the nucleotide exchange reaction are rate 
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limiting.  In chapter III, under the condition of [GEF] > [GTP ] > [GTPase], GTP binding 
is rate limiting rather than GDP release.  Although not tested, it is likely that GTP binding 
will remain the rate limiting step under the condition [GTPase] ≥ [GEF] > [GTP] and 
GEF and nucleotide have a similar affinity for the GTPase.   Hence, one needs to be 
extremely cautious when interpreting the results of GEF mediated nucleotide exchange 
measured by labeled displacing nucleotides such as radioactive GTP or mant-GppNHp.  
For example, in pilot experiments a fixed low concentration of mant-GppNHp (10 μM) 
and varying concentrations of Cytohesin-1cd was used to determine if there was a 
preference for the different classes of Arfs in a FRET assay.  Uninterestingly, kcat(app)/ KM 
(app) for nucleotide exchange at 10 μM are nearly identical for the different classes of Arfs 
(data not shown).  However, when the displacing nucleotide concentration is increased to 
200 μM, the kcat(app)/ KM (app) mediated by Cytohesin-1cd on Arf1 is 6 fold higher than 
Arf6 (Table 2.1-2.2).  This discrepancy is likely due to rate limiting GTP binding at 10 
μM mant-GTP.  In other words, there is a build up of binary nucleotide free complexes 
and the experiment measures the rate at which the binary complex associates with GTP to 
form the ternary GEF•G•mant-GppNHp complex.  
 Since the free GTP concentration in cells is ca. 200-500 μM (52) and likely 
exceeds that of the GEF by 100 fold or more, measurement of GEF mediated GDP 
release rates may provide more physiologically relevant information on the specificity of 
GEFs for different substrates.  To rigorously monitor rate limiting nucleotide release, one 
can either measure the rate for formation of the binary nucleotide free intermediate 
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between GEF and GTPase in the absence of displacing nucleotide, or empirically 
determine the value for Kg with Eqn 4a/4d.  Kg approximates the half maximal nucleotide 
concentration for attaining saturating rates of nucleotide release under conditions where 
the rate of dissociation of binary nucleotide free complex is negligible.  The method of 
choice for determining rate limiting GDP release will depend on the individual 
GTPase:GEF system.  For example, at physiological concentrations of Mg2+, the mixing 
of NΔ17Arf1 and Sec7 results in a substantial amount of binary nucleotide free 
intermediate as compared to the undetectable amount of binary Rab5•Rabex-5 
intermediate.  Hence, one can determine the rate of intermediate formation for 
NΔ17Arf1•Sec7 but not for Rab5•Rabex-5, which requires empirical determination of 
Kg.  However, determining Kg has the practical downside of being time and reagent 
consumptive. 
 The interswitch toggle characteristic of Arf but not Rab GTPases may explain 
why more binary nucleotide free intermediate is detected in the NΔ17Arf1:Sec7 system 
under identical experimental conditions.  Full length Arf GTPases contain a N-terminal 
amphipathic helix that docks onto the interswitch beta hairpin to prevent cytosolic GEF 
activation.  In cells, partitioning of the myristoylated amphipathic helix with the 
membrane helps to reduce the barrier for the 7Å (two residues) register shift within the  
interswitch region.  Hence, Sec7 domains may have evolved a higher affinity for the 
nucleotide free GTPase to ensure that there is little reverse reaction in the toggling of the 
interswitch region.   
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Mg2+ dependency in nucleotide exchange 
 Mg2+ is one of the most abundant free divalent cations in cells (c.a. low mM) 
(199) and GTPases utilize Mg2+ to increase nucleotide affinity and decrease the energetic 
barrier for GTP hydrolysis.  To gain insight into the role of Mg2+ in intrinsic and GEF 
mediated nucleotide exchange, EDTA was utilized to reduce free Mg2+ to high nM levels.  
Interestingly, EDTA mediated dissociation of Mg2+ and nucleotide exchange in Arf and 
Rab GTPases is detected in two distinct, successive phases in the time courses monitored 
by intrinsic tryptophan fluorescence.  Molecular dynamics stimulations suggest that 
removal of Mg2+ from both Arf1•GDP and Rab6•GDP results in a groove between the 
switch region and the nucleotide-binding site (200).  Taken together with the data 
presented here, this observation suggests that the environment around the tryptophans in 
both Arf and Rab GTPases are different in the Mg2+ free and bound conformations.  
Investigating which tryptophan is responsible for the difference in fluorescence change 
might yield useful mutations for further dissection of the role of Mg2+ in GEF mediated 
nucleotide exchange. 
 Crystallographic analyses suggest that in GEF mediated nucleotide exchange 
reactions at physiological concentrations of Mg2+, the Mg2+ cofactor dissociates before 
GDP release (88, 188).  Since it is possible to measure the rate at which EDTA removes 
Mg2+ from the GTPase, one would hypothesize that the intermediate step of GEF 
mediated Mg2+ dissociation would also be observed by fluorescence techniques.  
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However, in the kinetics of Cytohesin-1cd and Rabex-5 cd mediated nucleotide exchange, 
a separate Mg2+ dissociation phase is not observed.  This is not due to GEF mediated 
Mg2+ dissociation becoming too fast to be measured as only one phase is observed even 
at very low GEF concentrations.  A more likely possibility is that, unlike EDTA mediated 
nucleotide exchange, there is no build up of a Mg2+ free intermediate because Mg2+ 
dissociation and nucleotide release are effectively concerted.   
 At low Mg2+ concentrations, it was found that Cytohesin-1cd and Rabex-5cd 
mediated nucleotide release rates were 5-7 fold faster than at physiological Mg2+ 
concentration.  This is expected, as at low Mg2+ concentrations, not only is the nucleotide 
less tightly bound to the GTPase than at high Mg2+ concentrations, but the acidic fingers 
of the GEFs can also occupy the Mg2+ binding site at a much faster rate.  However, at low 
Mg2+ concentrations, Rabex-5cd mediated Rab5 GDP release is 80 fold faster than 
GppNHp binding.  It was not investigated whether the same phenomenon occurs in the 
Cytohesin-1cd: Arf1 system.  We hypothesize that Mg2+ plays a direct role in the 
nucleotide exchange process.  Although most GTPases have similar affinity for GDP or 
GTP, the active GTP bound state has up to 1000 fold higher affinity for Mg2+ (47, 194).  
This is because the GTP bound state has additional contacts with Mg2+ through the water 
ligands and the γ phosphate.  Thus, at physiological concentration of Mg2+, little of the 
reverse reaction involving ternary GEF•G•GTP to binary GEF•G complex is expected.  
However, at low Mg2+ concentration, substantial cycling between the ternary 
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GEF•G•GTP and the binary nucleotide free complex can occur, resulting in a delay from 
GDP release to an activated state.  In addition, Mg2+ might also compete with the acidic 
fingers for binding to the GTPase.  It will be intriguing to test this hypothesis by 
comparing the affect of acidic finger mutations on the activation rate at high and low 
Mg2+ concentrations.  
 Most GTPases exploit the high cellular [Mg2+] for coordinating nucleotide 
binding but the Class III Arf, Arf6 seems to be an interesting exception.  Due to its low 
affinity for Mg2+, at a physiological concentration of Mg2+and nucleotide, it was found 
that Arf6 has about a 10 fold faster intrinsic rate of nucleotide exchange than Arf1.  In 
addition, adding saturating amounts of EDTA does little to accelerate nucleotide 
exchange, which when monitored by intrinsic tryptophan fluorescence shows a single 
phase corresponding to nucleotide exchange.  It has been shown that Arf6's weak affinity 
for Mg2+ can be partly attributed to perturbation of the Mg2+ coordination sphere by Ser 
38 (18).  Interestingly, Ser 38 is replaced by a conserved Ile in all other Arf GTPases.  
Mutating Ser 38 in Arf6 to Ile increases Arf6's affinity for Mg2+ and the reverse is also 
true if the Ile 42 in Arf1 is mutated to Ser (18).   
 As a consequence of the reduced affinity for Mg2+, Arf6 has evidently evolved to 
have higher basal levels of activation compared to other Arfs.  However, a 10 fold 
increase in the rate of exchange is rather insignificant compared to 103-105 fold 
acceleration by the catalytic cores of most GEFs at a physiological concentration of 
Mg2+.  A detailed kinetic analysis comparing GEF mediated nucleotide release and 
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exchange rate for Arf6 may help to clarify whether the low Mg2+ binding affinity of Arf6 
has functional significance beyond increasing the basal exchange rate.  Nevertheless, the 
following observations are worth pointing out.  Comparing the observed rate constants 
for nucleotide exchange at a GEF concentration of 0.8 μM and physiological 
concentration of Mg2+, the catalytic core of Cytohesin-2/ARNO accelerates nucleotide 
exchange 800 fold for Arf1 and 43 fold for Arf6 whereas the catalytic core of EFA6 does 
not stimulate exchange on Arf1 but mediates an 8 fold increase in the exchange rate for 
Arf6 (76).  The smaller stimulatory effects for Arf6 can be attributed to the higher basal 
exchange rate as a consequence of lower Mg2+ binding affinity.  Similar to what is 
observed for Rabex-5 mediated Rab5 exchange at low Mg2+ concentrations, it is possible 
that Arf6 futilely cycles between the ternary GEF•Arf6•GTP and binary GEF•Arf6 
complexes.   
 
Nucleotide exchange by full length Cytohesin-1 and Rabex-5  
 At physiological concentrations of Mg2+, the catalytic cores of Cytohesin-1 and 
Rabex-5 robustly accelerate nucleotide release by at least 105 fold for their cognate 
substrates with the highest kcat (> 11 s-1) and KM (> 100 μM) values for any GEF:GTPase 
system examined to date.  Interestingly, full length Cytohesin-1 and Rabex-5 are both 
membrane targeted, which reduces the effective KM for catalysis, and are both 
autoregulated, which minimizes basal activation of GTPases.  For the Cytohesin family, 
biochemical and structural analyses show that the Sec7-PH linker and an amphipathic C-
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terminal helix bind to the Sec7 domain and occlude the docking site for Arf GTPases.  
Although the structure of full length Rabex-5 remains unsolved, biochemical experiments 
suggest that the catalytic core of Rabex-5 is autoinhibited by a predicted amphipathic 
helix C-terminal to the Vps9 domain.  
 Biochemical studies in vitro support a model in which activation of Cytohesin-1 
and Rabex-5 is coupled to membrane targeting.  For Cytohesin-1, relief of autoinhibition 
can occur on the membrane by PKC phosphorylation of the C-terminal helix or by 
phosphoinositide-dependent binding of active Arf6 to the PH domain and proximal 
autoinhibitory elements.  Intriguingly, active Arf1 and phosphoinositide have little effect 
on in vitro activation of Cytohesin-1 (Andrew Malaby, personal communication) even 
though the catalytic core of Cytohesin-1 has 6 fold higher catalytic efficiency for Arf1 
(18×104 M-1 s-1) than Arf6 (3×104 M-1 s-1) (Table 2.1-2.2).  Furthermore, it has been 
shown that normally cytoplasmic or Golgi localized Arf1 can be recruited onto the 
plasma membrane by overexpression of either constitutively active Arf6 or members 
from the Cytohesin family (161, 201).  Likewise, the level of active Arf1 also increases 
with overexpression of either constitutively Arf6 or members of the Cytohesin family 
(161).  Taken together, these observations suggest that Arf6-GTP may initiate a signal 
transduction cascade to target and activate Cytohesins at the plasma membrane, and 
subsequently Cytohesins may recruit and activate additional Arf GTPases on the plasma 
membrane.  The need for a signal transduction cascade to activate multiple Arf GTPases 
on the plasma membrane has been attributed to acute events such as Fcγ receptor 
mediated phagocytosis (202).  In phagocytosis, a significant change in the lipid 
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component of the plasma membrane is needed to form a phagosome.  This can be 
achieved by activation of multiple Arf GTPases to recruit different lipid modifying 
enzymes (1).  However, more direct experiments are needed to confirm the signal 
transduction cascade in different cell types. 
 For Rabex-5, partial relief of autoinhibition is achieved by binding to the Rab5 
effector Rabaptin-5 via the C-terminal helical region (57).  Activation of Rab5 by Rabex-
5 may recruit Rabaptin-5 to setup a positive feedback mechanism for further activation of 
Rabex-5.  The literature conflicts as to how Rabex-5 is targeted to endosomes, but a 
signal transduction cascade involving active Rab22, which is a member of the Rab5 
subfamily, has been implicated (197, 203).  This would directly link Rabex-5 activity to 
the levels of active Rab5 and Rab22.  It will be exciting to investigate if indeed active 
Rab22 can initiate a signal transduction cascade resulting in activation of Rab5 in a 
manner analogous to the putative Arf6-GTP/Cytohesin-1 pathway for activation of Arf1.   
 The signal transduction cascades down stream of active Arf6 and Rab5 have been 
studied in detail; however, the upstream signals and the players involved in the initial 
activation of Arf6 and Rab5 remain unclear.  As pointed out in the introduction, in 
addition to the four Cytohesins, there are 11 other mammalian Sec7 domain proteins, and 
some like EFA6 has been implicated in the activation of Arf6.  The field will benefit 
from a quantitative comparison of the exchange activity and Arf specificity of the 
isolated Sec7 domains as well as full length proteins to determine whether other Sec7 
domain families are autoregulated.  An analogous situation is emerging for Rab5, as there 
are 10 mammalian Vps9 domain proteins and seven mammalian proteins that belong to 
 152 
the Rab5 subfamily.  The most straightforward, though perhaps simplistic, explanation as 
to why there are more Sec7/Vps9 containing proteins than potential substrates is that 
some of the GEFs are functionally redundant or have tissue specific expression patterns.  
However, it seems more likely that different Sec7/Vps9 family of proteins can initiate or 
take part in different Arf/Rab related signal transduction cascades.  For example, both the 
BFA sensitive Big family and the BFA insensitive Cytohesin family Sec7 domain GEFs 
have high exchange activity for Arf1 (86).  However, while Arf1 and Cytohesin-1 are 
implicated in Fcγ receptor mediated phagocytosis, the Big family of GEFs do not appear 
to contribute substantially to this process as addition of BFA does not affect Fcγ receptor 
mediated phagocytosis (202, 204).   
 Finally, there are few reports on how GEFs return to the autoinhibited state upon 
signal termination.  The author would like to propose three general ways on how this can 
occur using the better characterized Cytohesin-3/Grp1 as an example.  The first way to 
convert a GEF back to the autoinhibited state is by a change in localization upon signal 
withdrawal.  Cytohesin-3 is initially targeted to the plasma membrane mainly through 
binding of its PH domain to PtdIns(3,4,5)P3 and is subsequently retained through 
PtdIns(3,4,5)P3-dependent binding to Arf6-GTP.  Hence, Cytohesin-3 can be returned to 
the cytosol when either PI3K is inactivated and/or PtdIns(3,4,5)P3  phosphatases are 
activated.  A second way to reverse GEF activation is to recruit higher affinity effectors 
to displace Arf6-GTP from the activated GEF.  It is found that the Ins(1,3,4,5)P4 
dependent binding of Arf6-GTP to Cytohesin-3 has a Kd  of 12 μM whereas the JNK-
interacting protein 4 (JIP4) has an substantially lower apparent Kd of 0.5 μM for Arf6-
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GTP (205).  Competition between effectors in different cellular contexts could in 
principle provide an additional layer of control over individual signaling pathways.  
Another way to reverse GEF activation may be to recruit multi-domain GAPs to change 
the localization of GEFs.  Many Arf GAPs contain a PH domain and the Centaurin family 
of Arf GAPs contain five predicted PH domains.  It is possible that the Centaurin family 
Arf GAPs could compete with Cytohesins for PtdIns(3,4,5)P3, in addition to accelerating 
GTP hydrolysis, and thereby displace Cytohesins from the membrane in conjunction with 
deactivation of stimulatory and/or substrate Arf GTPases. 
 
Conclusions and Future Perspectives 
 This thesis investigated the catalytic and autoinhibitory mechanisms in Sec7 and 
Vps9 domain exchange factors for Arf and Rab GTPases.  Even though the catalytic 
domains of Cytohesin-1 and Rabex-5 have unrelated folds, both GEFs can integrate 
various cellular signals to robustly activate cognate GTPases.  The studies presented in 
this thesis provide a solid structural and mechanistic foundation for future experiments to 
investigate the spatial-temporal dynamics of Cytohesin and Rabex-5 activation in cellular 
contexts.  Much exciting work lies ahead in understanding the multi-functional roles and 
the mechanisms that GEFs have evolved to synchronize the catalytic outputs with 
upstream inputs.  
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